WO2002010761A1 - Microreseaux et leur fabrication par tranchage - Google Patents

Microreseaux et leur fabrication par tranchage Download PDF

Info

Publication number
WO2002010761A1
WO2002010761A1 PCT/US2001/023632 US0123632W WO0210761A1 WO 2002010761 A1 WO2002010761 A1 WO 2002010761A1 US 0123632 W US0123632 W US 0123632W WO 0210761 A1 WO0210761 A1 WO 0210761A1
Authority
WO
WIPO (PCT)
Prior art keywords
interest
fibers
agent
fiber
microarray
Prior art date
Application number
PCT/US2001/023632
Other languages
English (en)
Inventor
N. Leigh Anderson
Norman Anderson
James Braatz
Original Assignee
Large Scale Proteomics Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/628,339 external-priority patent/US6846635B1/en
Priority claimed from US09/772,974 external-priority patent/US6653151B2/en
Priority claimed from US09/774,794 external-priority patent/US20020015952A1/en
Application filed by Large Scale Proteomics Corporation filed Critical Large Scale Proteomics Corporation
Priority to AU2001280833A priority Critical patent/AU2001280833A1/en
Publication of WO2002010761A1 publication Critical patent/WO2002010761A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/5436—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand physically entrapped within the solid phase
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00497—Features relating to the solid phase supports
    • B01J2219/00513—Essentially linear supports
    • B01J2219/00515—Essentially linear supports in the shape of strings
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00497—Features relating to the solid phase supports
    • B01J2219/00513—Essentially linear supports
    • B01J2219/0052—Essentially linear supports in the shape of elongated tubes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00497—Features relating to the solid phase supports
    • B01J2219/00513—Essentially linear supports
    • B01J2219/00524—Essentially linear supports in the shape of fiber bundles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/0054—Means for coding or tagging the apparatus or the reagents
    • B01J2219/00547—Bar codes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00585—Parallel processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00596—Solid-phase processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/0061—The surface being organic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00612—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports the surface being inorganic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00614—Delimitation of the attachment areas
    • B01J2219/00621—Delimitation of the attachment areas by physical means, e.g. trenches, raised areas
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00623—Immobilisation or binding
    • B01J2219/00626—Covalent
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00632—Introduction of reactive groups to the surface
    • B01J2219/00637—Introduction of reactive groups to the surface by coating it with another layer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00639—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium
    • B01J2219/00644—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium the porous medium being present in discrete locations, e.g. gel pads
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00659—Two-dimensional arrays
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00664—Three-dimensional arrays
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00673—Slice arrays
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068—Means for controlling the apparatus of the process
    • B01J2219/00702—Processes involving means for analysing and characterising the products
    • B01J2219/00707—Processes involving means for analysing and characterising the products separated from the reactor apparatus
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00722—Nucleotides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00731—Saccharides
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/12—Libraries containing saccharides or polysaccharides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B70/00—Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes

Definitions

  • the instant invention relates to microarrays containing bioreactive molecules, uses thereby and methods for manufacture thereof.
  • the arrays are constructed by sectioning bundles of tubules or rods, each containing unique reactants to produce large numbers of identical arrays.
  • a microarray is essentially a two-dimensional support or sheet wherein different portions or cells (sectors) of the support or sheet carry different biomolecules or elements, such as, nucleotides, polynucleotides, peptides, polypeptides, saccharides or polysaccharides, bound thereto.
  • Microarrays are similar in principle to other solid phase arrays except that assays involving such microarrays are performed on a smaller scale, allowing many assays to be performed in parallel. Microarrays have been used for a number of analytical purposes, typically in the biological sciences.
  • the initial screening (locating the target bead(s)) takes only days, the makeup of each identified hexapeptide is unknown, and the analysis and synthesis for confirmation and further work takes much longer. Such sorting and resorting becomes too burdensome and labor intensive for the preparation of large arrays of peptides. Further, this process can be characterized as not calling for a continuous support, and it is not addressable.
  • the probes are applied to a chip with a pin or a pipette in the pattern of an array and immobilized by any of a variety of techniques such as adsorption or covalent linkage.
  • An example of such DNA arrays is described in Stimpson et al. Proc. Natl. Acad. Sci. USA Vol. 92, pp. 6379-6383, July 1996. Since elements of the array are formed by the application of a DNA solution to the surface of the array the process is relatively slow.
  • VLSIPS.TM. technology has provided methods for making very large arrays of oligonucleotide probes in very small arrays. See U.S. Pat. No.
  • a common limitation to many of these methods is due to depositing liquids on surfaces, i.e., "spreading.” For example, spreading occurs on derivatized surfaces, such as those used in DNA immobilization on glass supports, because the solid support- surface becomes hydrophilic upon derivatization. As a result, when the DNA (desired to be immobilized upon the solid support) is contacted with the surface of the solid support, it spreads, rather than remaining in a discrete "spot.” Spreading is a major constraint on array density (i.e., the number of different spots that can be arranged on a single solid support). Hence, any means to curtail spreading, and so increase array density, is highly desirable. Additional problems arise with the density of biomolecule spotted on the solid support. Droplets of liquid will form a meniscus, which inherently causes uneven
  • the total amount of biomolecule deposited on the region of the microarray is limited to the maximum amount soluble in the droplet. For insoluble or low solubility molecules, this becomes a limiting factor.
  • each element of each array is a unique synthesis or an application step. This is true even when array elements or entire arrays are simply duplicated or produced "in parallel", or more accurately, concurrently. Since each element is a unique synthesis or application there is a chance for variation between corresponding elements on different arrays or, for that matter, duplicated elements on the same array. Even in a photolithographic process, increasing the number of chips on a wafer (the substrate on which multiple arrays are produced) results in an increase in surface area, which increases demand on the chemicals used in photo-chemistry (assuming no change in chip size).
  • Biochemical molecules on microarrays have been synthesized directly at or on a particular cell (sector) on the microarray, or preformed molecules have been attached to particular cells (sectors) of the microarray by chemical coupling, adsorption or other means.
  • the number of different cells (sectors) and therefore the number of different biochemical molecules being tested simultaneously on one or more microarrays can range into the thousands.
  • Commercial microarray plate readers typically measure fluorescence in each cell (sector) and can provide data on thousands of reactions simultaneously thereby saving time and labor.
  • a representative example of a patent in the field is U.S. Pat. No. 5,545,531.
  • two dimensional arrays of macromolecules are made either by depositing small aliquots on flat surfaces under conditions which allow the
  • each microarray is individually and separately made, typically is used only once and cannot be individually precalibrated and evaluated in advance. Hence, one depends on the reproducibility of the production system to produce error-free arrays. Those factors have contributed to the high cost of currently produced biochips or microarrays, and have discouraged application of the technology to routine clinical use.
  • CCD charged coupled device
  • Such devices generally detect light sources or light absorbance.
  • an array is located at the ends of a bundle of optical fibers with the nucleic acid or antibody/antigen attached to the other end of the optical fiber. Detection of fluorescence then may be performed through the optical fiber, for example, see U.S. Pat. No. 5,837,196.
  • Fiber optical arrays can be produced in which glass or plastic fibers are aligned
  • Parallel arrays also may be made of hollow glass fibers, and the array sectioned normal to the axis of the fibers to produce channel plates used to amplify optical images. Such devices are used for night vision and other optical signal amplification equipment.
  • Channel plates have been adapted to the detection of binding reactions (U.S. Pat. No. 5,843,767, not prior art) with the individual holes being filled after sectioning of the channel plate bundle, and discrete and separate proteins or nucleic acids being immobilized in separate groups of holes.
  • Hollow porous fibers have been used for dialysis of biological samples, for example, in kidney dialyzers and for water purification. Methods for aligning the fibers in parallel arrays, for impregnating the volume between the fibers with plastic, and for cutting the ends of such arrays have been described (see, for example, U.S. Pat. No. 4,289,623).
  • Immobilized enzymes have been prepared in fiber form from an emulsion as disclosed, for example, in Italy Pat. No. 836,462. Antibodies and antigens have been incorporated into solid phase fibers as disclosed in U.S. Pat. No. 4,031,201.
  • a large number of other different immobilization techniques are known in the fields of solid phase immunoassays, nucleic acid hybridization assays and immobilized enzymes, see, for example, Hermanson, G.T., Bioconjugate Techniques. Academic Press, New York. 1995, 785 pp; Hermanson, G.T., Mallia, A.K. & Smith, P.K. Immobilized
  • biochips include only one class of immobilized reactant, and perform only one class of reactions. For many types of clinical and other analyses, there is a need for chips that can incorporate reactants immobilized in different ways in one chip.
  • the instant invention relates to a method for producing rods or tubules, each containing a different entrapped or attached biological agent of interest; for arranging
  • the present invention also relates to a method for forming a predefined pattern of compounds or biological materials on a solid support where the compounds or materials are present in a matrix forming a solid. Individual compounds or biological materials are held in different portions of the matrix or separate matrixes bundled together prior to contacting the solid support. Actual deposition of the compounds or biological materials occurs when the matrix is removed/degraded/melted/partitioned from the compounds or biological materials or otherwise reversibly attached so that the compounds or biological materials are free to bind to the solid support. More particularly, the present invention relates to a method for producing a microarray comprising immobilized chemicals or components at predefinable addresses by dry dispensing such materials onto solid surfaces.
  • the invention relates to a method of dry dispensing bio-reactive components to a surface such that the components are uniformly distributed within a defined area at a high density on the surface.
  • the method comprises placing a solid containing compounds or components in a solidifying matrix onto a surface, degrading the matrix and retaining the entrapped compounds or components on the surface at the predefined locations by adherence thereto.
  • retaining the reactive compounds comprises displacing the matrix, where the displacing step uniformly deposits the entrapped bio-reactive samples on the solid surface.
  • Such displacement can comprise the use of abutting the matrix on at least one porous membrane comprising the solid surface.
  • the bio-reactive samples are embedded or immobilized in a meltable/removable/degradable/dissolvable or otherwise reversible matrix, which comprise rods or tubules.
  • a meltable/removable/degradable/dissolvable or otherwise reversible matrix which comprise rods or tubules.
  • Each rod or tubule may contain different or identical entrapped material samples.
  • the rods or tubules can be used for checking that all elements of the bundle maintain a constant arrangement or pattern throughout the length of the bundle after immobilization embedding and for sectioning the bundle to produce large numbers of identical chips for forming the desired pattern on the solid surface.
  • the resulting arrays are used for performing a variety of different quantitative biochemical analyses based on enzymatic activities, immunochemical activities, nucleic acid hybridization and small and large molecule and complex binding. These analyses are performed under conditions yielding to detection by fluorescence, optical absorbance or chemiluminescence signals, for acquiring images of these signals that are electronically processed and compared to produce clinically and experimentally useful data.
  • the components can include, but are not limited to biological macromolecules, complexes, organelles, biological cells (i.e., prokaryotic and eukaryotic) and viruses.
  • the macromolecules can include, but are not limited to proteins, carbohydrates, nucleic acids and lipids.
  • the solid containing coating agent and matrix is formed from slices obtained from a solid fiber, filament or tube.
  • the invention relates to long fibers, filaments or tubes comprising a meltable/removable/degradable/dissolvable matrix that contain or have the compounds or components embedded/immobilized therein, and methods for their manufacture. More specifically, microarrays are constructed in part by sectioning bundles of tubules or rods containing matrix immobilized molecules to produce large numbers of chips. The chips so produced are further processed by deposition to form microarrays. The deposited chips are subsequently manipulated to partition the immobilizing matrix away from the desired molecules or components, and to place said partitioned molecules onto the surface of the microarray.
  • the matrix can be made from various materials including, but not limited to super-cooled liquids, crystals, crystal polymers, non-crystal polymers, gels, waxes, emulsions, highly thickened or very viscous liquids, colloid suspensions
  • the matrix may be as simple as ice.
  • the present invention improves the well known spotting technique for making microarrays by completely avoiding any possibility of droplets smearing, spilling, mixing with its neighbor, etc. by "spotting" with a solid rather than a liquid.
  • the present invention also increases the amount per unit area of protein/DNA/viruses/biological cells/ various organic compounds coated on the slide
  • the present invention also allows one to place more addressable locations/cells per square centimeter of solid phase (e.g., the slide etc.) because a solid rather than a liquid is depositing the material.
  • the invention relates to long filaments or tubes that contain, are coated with, or have an agent of interest embedded therein, and methods for manufacture thereof.
  • the invention in another aspect, relates to a device comprising a substrate or solid phase having at least two (2) opposing major surfaces and multiple discrete channels extending to at least the two opposing surfaces. Further, the channels may comprise a first and second binding reagent immobilized on the walls of a first and second group of channels, hi a related aspect, the binding reagents may or may not be identical. In a further aspect, the invention relates to a device comprising a rigid support that is integral to a substrate or solid phase or is bonded to a substrate or solid phase.
  • the substrate or solid phase has a flat surface and a plurality of structures projecting away from the plane of the solid phase. Moreover, such structures may be permeable or impermeable to fluids.
  • the invention also relates to methods for arranging the fibers to form bundles in which the position of each fiber relative to all others is retained throughout the bundle length.
  • the invention further relates to means and methods for attaching or gluing all of the fibers together over the entire length thereof.
  • the invention relates to the preparation of microarrays wherein the elongated filaments or tubes are bundled together and cut transversely
  • a further aspect of the invention is the inclusion of markers which are either integral with the tubes or fibers or are contained in the media contained in hollow fibers which allow the fibers to be distinguished along the entire length thereof.
  • An additional aspect of the invention includes means for illuminating fibers individually at one end of a bundle, and identifying the other end by photoelectric means to confirm the integrity of the fiber arrangement.
  • the instant invention relates to forming a fiber containing an agent of interest, or means for immobilizing one or a class of agents of interest thereto.
  • the invention relates to means for embedding or attaching whole or fragments of biological cells, tissues or infectious agents to fibers or tubules in such a manner that the biologicals are exposed on the cut end of each fiber of tubule.
  • the array consists of tubules containing gel or other polymerizing materials that adhere to the tubing walls.
  • agents of interest are attached to the polymerizing or suspending medium in the lumen of small tubes.
  • the agents of interest are attached to particles that are suspended in a polymerizing medium, which suspension is used to fill tubules used to make array bundles and arrays.
  • the invention further relates to a method for the large scale production of identical flat two-dimensional arrays of immobilized nucleic acid-based agents for use in nucleic acid sequencing, in the analysis of complex mixtures of ribonucleic acids (RNA's) and deoxyribonucleic acids (DNA's), and in the detection and quantification of other analytes including proteins, polysaccharides, organic polymers and low molecular mass analytes, by sectioning long bundles of melt- able/removable/degradable/dissolvable comprising fibers or tubes.
  • Large scale production of other identical flat surfaces having a pattern of compounds or materials may be prepared by the same methods.
  • the invention relates to exploiting microarrays for mass screening of large numbers of samples from one to a large number of agents of interest.
  • the invention relates to the development of sets of tests on different chips or microarrays done in optionally branching sequence, which reduces the cost, delay and inconvenience of diagnosing human diseases, while providing complex data ordinarily obtained by time-consuming sequential batteries of conventional tests.
  • the invention relates to the fabrication of identical arrays that are sufficiently inexpensive to allow several identical arrays to be mounted on the same slide or test strip, and cross-compared for quality control purposes.
  • the invention relates to the incorporation of a non- fluorescent dye or other light absorbing material in the substance of the array to control the depth to which light used to excite fluorescence penetrates the array, thereby controlling the depth to which fluorescence analytes are detected, and insuring that fluorescent analytes which diffuse too deeply into the content of the cells, and therefore do not diffuse out, are not detected.
  • the invention relates to methods for determining that tubules are completely full of support media, and lack voids or air bubbles.
  • the invention relates to methods and apparatus for completely filling small tubes with a supporting medium using hydrostatic force or centrifugal force.
  • the invention relates to the reproducible manufacture of biochips or microarrays for bioanalysis.
  • the invention relates to the design and production of arrays, which are specifically designed to detect and diagnose a specific disease.
  • the instant invention relates to multiwell plates and
  • the invention relates to increasing the dynamic range of multiple-parallel assays by providing means for making serial measurements of fluorescence or absorbance over time, and for determining the rate of change of fluorescence or absorbance in each element of the array over time.
  • biochips that are inexpensive and sufficiently standardized to allow more than one to be used for each analysis, and for controls and standards to be run routinely and simultaneously in parallel.
  • sections from different portions of the bundle or different ends may be used.
  • One way of sectioning from different portions of the bundle is to cut or bend the bundle in the middle and align the two halves to form a single larger bundle thereby producing a section where each fiber is represented twice.
  • this invention relates to the production of chips in which the array elements or cells may differ form one another in the composition of the tubes, supporting medium, immobilization surface, immobilization matrix, or the class of agent of interest may be different in different cells.
  • Different matrices may be used for immobilizing different chemicals or components as needed and have different dissolving rates and degradation conditions.
  • the invention relates to the production of chips in winch the array elements or cells (sectors) may differ from one another in the composition of the tubes, supporting medium, immobilization surface, or the class of agent of interest may be different in different cells (sectors).
  • the invention relates to the production of chips in
  • 41834NewPCT combd micro.doc 12 which different types of reactions may be carried out at the surface of each cell (sector) of the array, with the reactions including immunological, enzymatic, hybridization or other binding reactions.
  • a further aspect of this invention relates to the production of subarrays of fibers or tubules adhering together to form one-dimensional ribbon-like arrays which may be separately stored.
  • the "ribbons" may be subject to quality control analysis before being assembled into two-dimensional arrays. Different one-dimensional arrays may be used to assemble different arrays, thus providing the option of producing custom-made arrays to meet specific research and clinical requirements.
  • the invention further relates to the development of multiple parallel chip- based methods involving continuously increasing temperature such that temperature sensitive reactions may be carried out at physiological temperatures, followed by an increase in temperature to allow hybridization reactions to occur.
  • the invention relates to preparing libraries of compounds with each fiber containing one of the compounds.
  • Libraries of cells, microorganisms, and subcellular structures may also be prepared and used.
  • the array may be used to simultaneously screen all of the compounds for a particular chemical or biological activity or conversely to screen a candidate compound against a number of biological materials.
  • Figure 1 is a schematic of intermediate products in the process for producing microarrays.
  • Figure 2 is a schematic of an individual tubule containing beads with immobilized ligands embedded in a gel.
  • Figure 3 is a schematic of an individual tubule containing a gel with ligands attached to the gel.
  • Figure 4 is a schematic of an array with ligands attached to the inner walls of cells, and with means for closing off one surface of the array to form a set of micro wells.
  • Figure 5 is a schematic of a means for insuring that all fibers are maintained in
  • Figure 6 is a schematic of means for identifying arrays.
  • Figure 7 is a schematic for scanning an array.
  • Figure 8 displays an alternative way of forming a fiber bundle.
  • Figure 9 is a cross-sectional view of a sliced section on a solid surface and the steps involved in preparation of the final microarray.
  • binding component may be any of a large number of different molecules, biological cells or aggregates, and the terms are used interchangeably to describe various compounds or materials.
  • Each binding component is immobilized at a cell, sector, site or element of the array and binds to an analyte being detected. Therefore, the location of an element or cell containing a particular binding component determines what analyte will be bound.
  • nucleotides oligonucleotides and polynucleotides
  • antibodies ligands, saccharides, polysaccharides, microorganisms such as bacteria, fungi and viruses, receptors, antibiotics, test compounds (particularly those produced by combinatorial chemistry), plant and animal cells, organelles or fractions of each and other biological entities may each be a binding component if immobilized on the chip and/or subsequently deposited on the solid surface.
  • they may also be considered analytes if they bind to a binding component immobilized in a chip, where the immobilized component is subsequently deposited on the solid surface.
  • a binding component immobilized in a chip where the immobilized component is subsequently deposited on the solid surface.
  • the high molecular weight refers to greater than 100 amino acids, nucleotides or sugar molecules long.
  • bind includes any physical attachment or close association, which may be permanent or temporary. Generally, an interaction of hydrogen bonding, hydrophobic forces, van der Waals forces, covalent and ionic bonding etc., facilitates physical attachment between the molecule of interest and the analyte being measuring.
  • binding may be brief as in the situation where binding causes a chemical reaction to occur. That is typical when the binding component is an enzyme and the analyte is a substrate for the enzyme. Reactions resulting from contact between the binding agent and the analyte are also within the definition of binding for the purposes of the present invention.
  • cells refers to a unit component of an array identified by a unique address, which generally differs from other cells, sectors, sites or elements by content as well as location.
  • Biological cells generally are referred to by type, e.g. microorganisms, animal and plant cells.
  • fibers includes both filaments and hollow capillary structures.
  • Filaments or rods may be solid strands of monolithic, porous or composite forms, or aggregate forms. Pluralities, typically a large number, of fibers are bound adjacent to each other in ribbons or bundles to form a "fiber bundle.”
  • a fiber bundle may constitute a portion of the actual bundle being used such as ribbon.
  • the cross-section of the fibers may be of any shape, such as round, triangular, square, rectangular or polygonal.
  • surface refers to the exterior boundaries of an object.
  • Particle includes a large number of insoluble materials of any configuration, including spherical, thread-like, brush-like and many irregular shapes. Particles are frequently porous with regular or random channels inside. Examples include silica, cellulose, Sepharose beads, polystyrene (solid, porous and derivitized) beads, controlled-pore glass, gel beads, sols, biological cells, subcellular particles, microorganisms (protozoans, bacteria, yeast, viruses, etc.) micelles, liposomes, cyclodextrins, two phase systems (e.g. agarose beads in wax) etc. and other structures which entrap or encapsulate a material. Particularly preferred are recombinant hosts and viruses that express the protein of interest.
  • interconnecting refers to the adhesion of the surfaces of the fibers without actually melting the whole fiber. Sintering may be chemical or thermal and may even
  • New PCT combd micro.doc 15 involve a self adhesive component that may be activatable.
  • dry dispensing refers to depositing binding components in a solidifying matrix to a solid surface without applying using a liquid vehicle. Further, the matrix is removed in such a way as to retain the comprising bio-reactive sample on the solid surface.
  • a dry dispensed product may contain water or other liquid, as long as it retains a solid shape during handling. hr a preferred embodiment, the solid phase surface is selected from the group consisting of glass, ceramics, Teflon coated materials; organic polymers and biopolymers.
  • binding molecules such as, but not limited to for example, protein G, protein A, sfreptavidin, biotin, receptors, ligands, lectins, and nucleic acids, are prebound to a solid phase surface.
  • This binding can be done by any means known in the art such as, but not limited to, the methods of Burzio et al. (U.S. Patent No. 5,817,470), L ⁇ fas et al. (U.S. Patent No. 5,716,854), Thust et al. (U.S. Patent No. 5,955,335) and Hiriade et al. (U.S. Patent No. 5,736,099).
  • These prebound materials may act to immobilize agents of interest after the matrix is removed.
  • uniformly distributed refers to a substantially equal concentration of bio-reactive components within a defined analysis field (area).
  • porous membrane refers to a surface that will allow for the partitioning of a matrix (e.g., once a change in physical state of the matrix has occurred, solid to fluid), away from the immobilized components in said matrix.
  • the porous membrane abuts or is the solid surface, wherein such abutting allows for complete removal of the matrix from the solid surface by, for example, passage through the membrane.
  • the sample could be partitioned by electrophoresing the sample out of the matrix onto a porous membrane (e.g., Western transfer).
  • Meltable matrix “Removable matrix,” “degradable matrix” “reversible matrix” and “dissolvable matrix” are interchangeable terms referring to any immobilizing medium that can: 1) in the solid state comprise a uniform dispersion of agent of interest as a suspension without substantially affecting the functional properties of the agent 2) be converted to a state, including, but not limited to a fluid and/or gas, that allows for facile partitioning away of said medium from said sample 3)
  • Ne PCTcomb micro.doc 1 be cleaved from a solid phase such as the inside walls of the fiber tube 4) be chemically or electrically altered to render unable to continue to immobilize the agent of interest, all without adversely affecting the functional properties of the agent.
  • meltable matrix is a low melting point waxes such as castor wax, steryl alcohol, many polymers, etc.
  • An example a removable matrix is a silica or other particulate thickened medium such as clays.
  • An example of a degradable matrix is protease digestible gelatin or amylase digestible starch or a pH, chemical or temperature sensitive matrix.
  • An example of a reversible matrix is alginate with calcium or sodium ions determined by the presence of a chelating agent and the like.
  • a soluble matrix is a sugar or soap with water as solvent or fatty acids with organic solvents. The list of possibilities is very long.
  • arrays and “microarrays” are used somewhat interchangeably differing only in general size.
  • the instant invention involves the same methods for making and using either.
  • Each array typically contains many cells (typically 100-1,000,000+) wherein each cell is at a known location and contains a specific component of interest.
  • Each array therefore contains numerous different components of interest.
  • device is used to describe both arrays and microarrays, where the array or microarray may comprise other defined components including surfaces and points of contact between reagents.
  • substrate is also a term used to describe surfaces as well as solid phases which may comprise the array, microarray or device.
  • the instant invention makes microarrays, "chips” or “biochips” by sectioning bundles of small plastic rods, fibers, tubes or tubules containing immobilized binding component, including biological molecules and entities such as nucleic acid fragments, nucleotides, antigens, antibodies, proteins, peptides, carbohydrates, ligands, receptors, drug targets, biological cells or subtractions thereof (e.g. ground-up cells, organelles, solvent extract etc.), infectious agents or subtractions thereof, drugs, toxic agents or natural products.
  • Embedding media may be, in the instant invention, polymerized or solidified in small tubes, or may be cast into rods or sheets.
  • the tubes may be of material such as glass, metal, ceramic or plastic.
  • New PCT combd micro.doc 17 immobilized binding components e.g. nucleic acids, proteins, cells etc.
  • immobilized binding components may be coated on the inside or outside of the microtubes, contained in a gel in the microtubes, or attached to or embedded in small particles or beads which fill the tubes.
  • the particles or beads may be a component of a gelling material or can be separate components such as latex beads made of a variety of synthetic plastics (polystyrene etc.).
  • the agent of interest is incorporated on or in the plastic before the filament is cast, extruded or pulled through a die. Each section cut constitutes a microarray for use in various binding assays.
  • a key aspect of the invention which provides an economic advantage, is that the fibers or tubules are prepared using only methods providing a functionality stable to long term storage are used. Unlike other methods involving protein containing liquids which must be prepared fresh each time, immobilized proteins in relatively dry form remain stable for great lengths of time, often without refrigeration.
  • each component of a future microarray separately in/on a fiber permits one to assay for and evaluate the functionality or reactivity of each component before being incorporated in an array.
  • Both the spotting technique and the in situ synthesis technique do not permit testing before completion.
  • quality control checks can sample only a small portion of such microarrays, which is unlike the instant invention where each fiber may be tested.
  • a 1mm diameter liquid droplet is generally at most 0.5 mm when on a solid surface.
  • a 1mm diameter solid cylinder may be 3 or more mm tall, potentially depositing six (6) times more protein/DNA etc. on the same area of surface given the same solubility of protein etc.
  • the same unit area of solid surface may have a considerably larger range of protein density.
  • the same applies different amounts of fluid and different surface areas and for any other agents of interest and the solid cylinder may be of almost any height.
  • Microarrays are known in the art and are commercially available from a number of sources. Microarrays have been used for a number of analytical purposes, typically in the biological sciences. An array is essentially a two-
  • Microarrays are similar in principle to other solid phase arrays except that assays involving such microarrays are performed on a smaller scale, allowing many assays to be performed in parallel.
  • Figures 1-7 Various aspects of the invention are illustrated in Figures 1-7.
  • General principles are illustrated in Figure 1 where rod or tube 1 incorporates an agent of interest.
  • the rods or tubes may be bonded into a flat parallel array 2, and multiple flat arrays then are bonded into the multiple parallel bundle 3.
  • the bundle 3 may be constructed in one step from a series of rods 1.
  • the end of bundle 3 is cut or sectioned to yield the final array 4 that contains one small section 5 of each rod or tube in the entire bundle.
  • the thin section 4 is mounted on a solid surface 6, which is to become the microarray. Remnants of the hollow fiber tube 8 separate remnants of individual fibers 7. After application of the matrix removing step, the agents of interest adhere to and form a layer 9 on the surface. Optional final removal of the remnants of individual fibers 7 yields a solid surface with a layer 9 in a predefined pattern of various agents of interest.
  • the hollow fibers may be filled with gels or particles including immobilized reactants, and the entire bundle sawed into arrays.
  • the rods or tubules comprising the sectioned bundle fall into at least eight classes, with subdivisions of each.
  • a first class is composed of solid rods or filaments with the immobilized binding component being part of the composition of the rod or filament.
  • the agent of interest in the instant invention may comprise a very broad range of chemicals, complexes, tissues, biological cells or fractions thereof. Nucleic acids, sugars, proteins, which may be modified or coated with detergents to enhance solubility in
  • Other methods for impregnating a solid fiber include mobilizing the agent of interest through the matrix of the solid fiber using an electromotive force.
  • the microarrays are produced by diffusion and entrapment after polymerization of the strands.
  • An element of a microarray is formed by preforming a polymeric strand, then incorporating a biological target molecule into the strand by a method including, but not limited to, diffusion from a solution containing the biological target molecule.
  • a method of incorporating labile biological target molecules into polymeric avoids harsh conditions of polymerization, such as heat, presence of free radicals etc. that might alter a biological target molecule. Further, such a method envisages entrapping the biological target molecule within the polymeric strand while concomitantly preventing subsequent diffusion of the biological target molecule out of the strand.
  • a polymeric strand of material can be prepared from a material such as, but not limited to, ImmiinoBed (Polysciences, Warrington, PA), polyacrylamide, agarose etc.
  • a mixture of monomeric substances can be mixed with an entrapping agent, such as but not limited to, protein-biotin complexes.
  • the mixture can then be introduced into tubing (e.g., polyethylene) and allowed to polymerize.
  • a strand thus formed can be extruded from the tubing mold and placed in a solution containing a biological target molecule of interest.
  • the biological target molecule of interest will be conjugated to a biotin-binding protein such as sfreptavidin.
  • binding pairs which are known in the art, are also envisaged for this purpose (e.g., antibody- antigen, nucleic acid-nucleic acid, protein-protein, protein-nucleic acid, receptor- ligand, lectin-antibody, cell-cell, etc).
  • the strand is allowed to remain in contact with the solution for a period of time, at a temperature that is consistent with maintenance of biological activity.
  • the temperature range is between about 4° C to about 70° C, more preferably about 4° C to about 40° C.
  • the temperature is chosen based on the solidifying properties of the matrix and the thermolabile properties of the agent of interest.
  • the period of time of contact between the strand and the solution for optimal incorporation of the biological target molecule into the strand will depend on many factors, including, but not limited to, porosity of the strand, molecular size of the biological target molecule, concentration of the biological target molecule, temperature etc.
  • a second class of fibers is not homogeneous and the polymerizing, solidifying matrix or gelling material also may contain solid structural elements such as filaments, branched elements etc., to further strengthen the gel and also may provide attachment sites for the agent of interest, moreover such materials allow for facile partitioning away of agents of interest from free agents.
  • Polystyrene latex or other plastic particles to which proteins or nucleic acids are attached are particularly preferred. Conditions can be arranged such that the supporting plastic is eroded to a depth of a few microns to reveal active subparticle surfaces, and do not dissolve the supporting plastic latex beads. For example, proteins derivatized with fluorinated groups attach strongly to Teflon ® microparticles.
  • Such derivatized Teflon ® particles in, other suitable embedding medium can be partially exposed at the plastic surface by a dilute solvent, composed. Alternatively, these particles may be embedded in a porous matrix.
  • the beads to which agents of interest are attached may be porous gel beads used in chromatography such as Sephadex, Biogels and others, or solid beads such as are used in chromatography.
  • a variety of methods for derivatizing these and for attaching proteins, nucleic acids and polysaccharides and small molecules thereto have been developed and are well known to those skilled in the arts.
  • the added components serve to strengthen the gel and may provide attachment sites for inclusions including dendrimer branched polynucleic acids, branched or crosslinked polymeric materials, metal or glass fibers.
  • Threads, yarn-like configurations and brush-like configurations of structural elements may be cast into the length of the fiber to provide strength and to allow the fiber to be handled or dried more easily.
  • the structural elements may serve as the immobilizing component in the fiber for a desired binding component.
  • the structural elements may later adhere to the solid surface as a method for adhering the binding partner.
  • a third class of fibers includes extruded or cast plastic, which includes a
  • the second phase may be in the form of, for example, hydrocarbon, aqueous or fluorocarbon microdroplets, waxes, particles of sugars or other water soluble materials, or inorganic particles such as calcium carbonate particles, which can be dissolved in dilute acid to reveal active groups.
  • a solvent Brief exposure of the cut surface of a chip to a solvent will dissolve some of the inclusions, increasing the surface area of the support plastic containing the agents of interest and allowing them to adhere to the solid surface directly or indirectly via the porous solid.
  • These solid matrices can also be prepared which incorporate structural elements in the second class of fiber.
  • the material between the fibers can be removed, increasing the available surface on the exterior of the fiber for interaction between target and agent of interest.
  • each fiber may contain two or more materials possessing different properties such as, but not limited to, polyethylene fiber and an acrylamide gel with the protein.
  • the materials may be attached by a cyanoacrylate adhesive.
  • the glue may be made of a different material.
  • such mixed fibers may comprise the same or different protein immobilized in a matrix comprising one or more heterogeneous materials.
  • Solid plastics also can be prepared which incorporate polystyrene latex or other plastic particles to which proteins or nucleic acids are attached. Conditions can be arranged such that the supporting plastic is eroded to a depth of a few microns to reveal active subparticle surfaces, and do not dissolve the supporting plastic latex beads.
  • proteins derivatized with fluorinated groups attach strongly to Teflon ® microparticles.
  • Such derivatized Teflon ® particles in, for example, an acrylic plastic or other suitable embedding medium, can be partially exposed at the plastic surface by a dilute acrylic solvent, composed, for example, of methylene chloride and ethyl alcohol.
  • the particles may be embedded in a porous matrix.
  • the beads to which agents of interest are attached may be porous gel beads used in chromatography such as Sephadex, Biogels and others, or solid beads such as are used in chromatography.
  • porous gel beads used in chromatography such as Sephadex, Biogels and others
  • solid beads such as are used in chromatography.
  • tubule 6 is comprised of tube 7 containing gel 8 which supports particles 9.
  • An end view 10, and enlarged view 11 of the tubule shows exposed particles 12 at the cut end. Area 13 is shown additionally enlarged at 14 to illustrate the presence of immobilized reactants 15 on the surface of the exposed particles 12. Note that all rods described can be cast with a string or thread through the center thereof to increase strength, and to make the rods easier to handle.
  • a fourth class of fibers is prepared by sintering glass or plastic beads to form a porous material with a high surface to mass ratio.
  • Such material is conventionally made from glass, polytefrafluoroethylene (PTFE) (Teflon ® ), Teflon ® AF, polyethylene, polypropylene, can be manufactured from polystyrene and from a variety of other plastics. Heat, pressure or exposure to solvent vapors can sinter plastics.
  • the sintered material can be derivatized in sheets or in cut rods. Polystyrene is convenient from the point of view of coupling agents of interest thereto.
  • Teflon ® can be activated using solutions of metallic sodium in an organic solvent producing groups to which other plastics will adhere, and then may be derivatized.
  • Polyethylene and polystyrene can be activated by corona plasma discharge or by electron beam radiation.
  • An advantageous approach is to make sintered composites of polystyrene and polyethylene.
  • Nylon beads also can be sintered and derivatized. Other sintered materials are known or are under development, many of which will find application here.
  • Molecules of interest may be attached to the solid materials either before or after sintering.
  • the rods may be soaked in tubes containing the substance to be attached or the rods may be coiled up inside a hollow bowl centrifuge rotor having the general configuration of a zonal rotor (see Anderson, N.G., Natl. Cancer Inst. Monograph No. 21), but which may be centrifugally drained.
  • the solution of the substance to be attached then is centrifuged first into the sintered mass, and then out of it, followed by washing as necessary.
  • the sintered rods then may be dried, coated with a suitable adhesive, assembled into a bundle and sectioned.
  • the beads with agents and items of interest attached thereto may be extruded under pressure to form rods that then may be sintered together.
  • the assembled tubes may be held together with a variety of cements or polymerizeable plastics.
  • the outside of the tubes may be altered or treated so that cements or polymerizeable plastics will adhere thereto.
  • a fifth class of fibers is comprised of hollow impermeable tubules typically formed from plastics including, but not limited to, polyethylene, polypropylene, Teflon ® or polyvinyl chloride, and is filled completely with a gel or other polymerizing material to which agents of interest are attached directly or suspended therein.
  • the agents of interest may be reversibly or cleavably bound to the inner surface of these hollow tubes.
  • the external surfaces of the tubes may be modified chemically or physically to accept adhesives used to bind the bundled tubes together.
  • the tubes may be filled before or after bundling.
  • the internal surface also may be modified so that the gel or polymerizing mixture introduced into the tubes will adhere, preferably by covalent attachment.
  • Acrylamide derivatives may be linked to the wall to make an acrylamide gel adhere, while gelatin, agar, or agarose derivatives may be attached similarly to link with the respective gels.
  • Methods for linking agents of interest, such as, proteins and nucleic acids, to linear acrylamide, gelatin and agarose are well known, and the derivatized molecules can be incorporated into the gels used for casting.
  • Acrylamide can be made to gel at room temperature either chemically or using photoactivation, while low temperature-gelling Sepharose is available. Gelatin sets slowly and at temperatures below ambient.
  • the polymers used to fill the tubes are typically homogeneous, but may contain agents of interest, which become attached to the polymerizing medium.
  • Examples include covalent attachment of proteins to short acrylamide chains that become incorporated into acrylamide gels and proteins covalently linked to gelatin.
  • gels are available or can be produced which contain labile biomolecules without exposing them to denaturing temperatures.
  • the structure of such tubes is illustrated in Figure 3 where tube 16 is filled with a cross-linked gel 17 to which are attached agents of interest 18.
  • a side view 19 and end view 21 of a sectioned tube illustrates the availability of immobilized agents 21.
  • Arrays prepared using hollow fibers may have the interior of the fibers coated
  • Isocyanate polymers such as oxyethylene-based diols or polyols wherein most if not all of the hydroxyl groups thereof carry polyisocyanate groups are suitable. Some such polymers can be comprised of polyurea/urethane polymers. The polymers are well hydrated and fall in the category of hydrogels. Suitable starting materials include triols, such as glycerol, trimethylpropane and triethanolamine, tetrols and polyethylene glycols. Suitable polyisocyanates include diisocyanates and such.
  • the polyisocyanates can be aromatic, aliphatic or cycloaliphatic. (Braatz et al., U.S. Patent 5,169,720 and Braatz, J. Biomaterials Applications 9:71- 96 (1994)). Alternatively, a bundled array may be positioned so that individual hollow fibers may be filled with biopolymers in solutions that gel prior to sectioning.
  • a sixth class of fibers or tubes includes empty impermeable tubes with molecules of interest attached to the imier surface, but otherwise empty or made empty.
  • the sectioned chip 22 is comprised of sectioned plastic tubes 23 embedded in supporting plastic 24, with the agent of interest 25 attached to the inner walls of the tubes, leaving the center 26 open.
  • the result 27, seen in side section, has sectioned plastic tube 23, immobilized agent 25, yielding open holes 26, and all held together by supporting material 24.
  • the chips may be considered as ultramicrotiter plates and may be used for flow through analysis based on, for example, immobilized affinity ligand techniques (Hermanson et al., Immobilized Affinity Ligand Techniques, Academic Press, 1992, p 407), for polymerase chain reaction (PCR) amplification of immobilized oligonucleotides, or for other detection reactions and the like that can be accomplished at that scale, as described, for example, in U.S. Pat. No. 5,843,767.
  • the tubes are made of Teflon ® with the internal or external surfaces treated to become hydrophilic, the cut ends will remain hydrophobic.
  • the sandwiched structure 32 including chip 33 of Figure 4 may employ two pieces of material such as glass or quartz 34 to seal the ends of the tubes, creating microchambers 35. Changes in fluorescence or in optical absorbance 36 may be detected in each tubular element through the transparent end windows, and the reaction followed colorimetrically or fluorometrically.
  • a variety of other reactions may be performed inside the microarray or inside the hollow fiber used to prepare a microarray.
  • a polypeptide, polysaccharide or polynucleotide may be synthesized in situ and/or a library of combinatorial small molecules such as esters, amides, carboxylates etc., prepared.
  • the same reactions, including PCR, may be performed in any of the other types of fibers, including solid fibers if the fibers are sufficiently permeable to the reactants.
  • an array device comprising a solid phase and impermeable hollow fibers, where the hollow fibers form a multiple channeled surface.
  • a surface can comprise multiple and/or groups of channels where the channels are distinguishable by, but not limited to, differences in channel composition.
  • the channels can extend to at least two exterior surfaces of the solid phase.
  • the solid phase may be bound to or integral with a rigid solid support.
  • the rigid support comprises wells for delivering fluids to subsets of channels comprising the solid phase.
  • the channels comprise immobilized reagents that may be identical for each channel or group of channels or non-identical.
  • the channels have a range in diameter of between about 1 ⁇ m to about 3 ⁇ m. In another embodiment, the channels have a range in diameter of between about 0.45 ⁇ m to about 5 ⁇ m. In a preferred embodiment, the channels have a range in diameter of between about 0.05 ⁇ m to about 8 ⁇ m. In a more preferred embodiment, the channels have a range in diameter of between about 0.033 ⁇ m to about 10 ⁇ m.
  • such a device having discrete channels can have varying cross- sectional areas.
  • the cross-sectional area of the channels has a range of between about 1 x 10 "2 ⁇ m 2 to about 10 ⁇ m 2 .
  • the cross-sectional area of the channels has a range of between about 1 x 10 "3 ⁇ m 2 to about
  • the cross-sectional area of the channels has a range of between about 5 x 10 "3 ⁇ m 2 to about 60 ⁇ m 2 . In a more preferred embodiment, the cross-sectional area of the channels has a range of between about 8.5 x 10 "4 ⁇ m 2 to about 80 ⁇ m 2 . In a related aspect, the channels can also vary in inner surface area. In a preferred embodiment, the inner surface area of the channels is from about 100 to about 1000 times the cross-sectional area of the group of channels. In one embodiment, the inner surface area of the channels has a range of between about 100 ⁇ m 2 to about 1 x 10 3 ⁇ m 2 .
  • the inner surface area of the channels has a range of between about 50 ⁇ m 2 to about 5 x 10 3 ⁇ m 2 .
  • the inner surface of the channels has a range of between about 10 ⁇ m 2 to about 3 x 10 4 ⁇ m 2 .
  • the groups of channels can have varying areas on the exterior surface of the device.
  • the channels have areas in the range of between about 2 x 10 3 ⁇ m 2 to about
  • the channels have areas in the range of between about 200 ⁇ m 2 to about 1 x 10 5 ⁇ m 2 . In a preferred embodiment, the channels have a range of between about 100 ⁇ m 2 to about 3 x 10 5 ⁇ m 2 . In a more preferred embodiment, the channels have a range of between about 20 ⁇ m 2 to about 3 x 10 6 ⁇ m 2 .
  • the channels can vary in the number of channels per cm 2 of solid phase surface. For example, in one embodiment, the number of channels per cm 2 can be between about 600 to about 700. h another embodiment, the number of channels per cm 2 can be between about 500 to 1000. In a preferred embodiment, the number of channels per cm 2 can be between about 450 to about 2000. In a more preferred embodiment, the number of channels per cm 2 can be between about 400 to about 4400.
  • the microarray When hollow, the microarray may have no agent of interest immobilized thereon or therein. In such a situation, one has a very small multiwell plate, a commercial product per se. By placing, with or without immobilization, biological cells in "empty" hollow fibers; one can use the microarray to determine the cellular response to a specific agent. One may even coimmobilize a substrate or reagent with
  • New PCT combd micro.doc 28 the biological cells to stimulate production of a detectable product when contacted to or to interact with a specific analyte.
  • the immobilized agent of interest and reagent(s) may be dissolvable, meltable, degradable, or reversible (e.g. alginate with calcium ions or sodium EDTA) to further enhance interaction.
  • part of a fiber may contain an immobilized antibody in an insoluble polymer such as a polyurethane.
  • a labeled antigen is held in a water-soluble matrix such as 7% sodium stearate.
  • the unlabeled target antigens Upon adding a target sample, potentially containing unlabeled antigens in water, to a sliced bundle microarray of the fiber, the unlabeled target antigens compete for the immobilized antibody with labeled antigens once the soluble matrix has dissolved. Because the microarrays of the present invention are very thin, dissolving of the soluble matrix and free of the reagents is very quick.
  • Coextrasion and injection of one material inside the mass of a solid are two other preferred methods for ensuring close contact between the reagents and agents of interest.
  • the first consists of immobilized agents of interest.
  • the second consists of corresponding reagents entrapped in a soluble matrix.
  • One section of each are aligned and in contact with each other such that the end of one fiber contacts the end of another fiber.
  • the dissolving of the soluble matrix necessarily causes the reagent to contact the immobilized reagent of interest.
  • This contact is enhanced by using impermeable walled tubing to make the fibers and by sandwiching the reagent section between an impermeable solid phase and the section with immobilized agent of interest. In such an arrangement, the only way for the reagent to diffuse out of the microarray is to pass through the cell with immobilized agent of interest.
  • the inside surface of the small tube described may be modified chemically to allow attachment of polynucleotides, polypeptides, polysaccharides or other molecules either directly or through linkers.
  • the molecules attach, thus increasing the number of reactive sites inside the tube. Since DNA and RNA are conventionally synthesized on small polystyrene beads, the most direct approach to a nucleic acid array is to synthesize oligonucleotides on small polystyrene beads, with different batches of beads having different sequences attached, and then to fill small polyethylene, polypropylene, polystyrene or other plastic, metal or ceramic tubes with the beads, packing down to completely fill the tubes.
  • agents of interest can be attached to inner surfaces, such as, but not limited to, hollow fiber channels, by first derivatizing such agents using terminal primary amine groups and reacting the modified agents with an epoxysilane derivatized inner surface.
  • agents of interest can be attached to inner surfaces, such as, but not limited to, hollow fiber channels, by first derivatizing such agents using terminal primary amine groups and reacting the modified agents with an epoxysilane derivatized inner surface.
  • oligonucleotide probes can be attached to channel surfaces through primary amine groups incorporated into the probe prior to immobilization. Such derivatized probes are then reacted with epoxysilane present on the channel surface, which results in immobilization of the probe.
  • a seventh class of tubes or fibers includes tubules with permeable walls.
  • Methods and procedures for producing hollow selectively permeable fibers for use in kidney dialysis machines and for molecular weight fractionation have been developed (U.S. Pat. No. 4,289,623, U.S. Pat. No. 3,976,576) and are in wide current use. Procedures for embedding such fibers in solid sectionable plastics also have been
  • New PCT combd rnicro.doc 30 developed and are used to attach the fibers to tubing at the dialyzer ends.
  • Permeable hollow fibers may be used in the instant invention in two ways.
  • the fibers are filled with reactant-carrying gels while already embedded in plastic.
  • reactant-carrying gels By carefully splaying out the fibers going into the cast portion, each tube can be filled selectively as previously described. That technique offers the advantage of producing small arrays quickly, and of developing new assays without having to go through all of the steps required to produce separate hollow fibers, fill same with reactants, arrange same in arrays and infiltrate same with the supporting plastic.
  • the second method of use involves filling the hollow fibers before being embedded in plastic. Techniques have been developed for controlling the wall permeability of permeable tubes.
  • acrylamide gels may be produced from acrylamide and bisacrylamide by cross-linking with ultraviolet light in the presence of riboflavin. That technique is preferred when the specific binding component is heat sensitive or sensitive to other chemicals.
  • Another example is the use of hollow fibers porous to calcium ions where the agent of interest is mixed in a sodium alginate solution and pumped through the hollow fiber. When submerged in calcium chloride, calcium alginate gels form thereby entrapping the agent of interest. The gels are reversible in a chelating solution such as EDTA. Catalyst, which might interfere with subsequent fluorescence measurements, can be removed by dialysis through the tubing wall after polymerization.
  • Another gelling material is an isocyanate-containing prepolymer that polymerizes on contact with water and generates only carbon dioxide as a byproduct of polymerization.
  • the binding component may be incorporated onto solid phase(s) first or otherwise placed in the fiber, which then is polymerized and/or dried to incorporate the binding component to be used on hydration of the gel.
  • Permeable supporting tubing also allows the gel inside a tube to be infiltrated with substances that render the reactants more stable, increase the physical strength of the gel and facilitate sectioning.
  • substances such as lactose, trehalose, glycerol, fructose and other polyhydric alcohols may be introduced to stabilize
  • the additives may be removed partially from the exposed surface of the chip during use to make buried reactive groups available. Additives diffusing into the gels also may be used to increase the strength and volume of a gel after it has been dried. Also, when a particle containing the ligand or receptor is embedded in a fiber, the embedding medium may be soluble or meltable so as to be removable after the microarray is formed. By removing the embedding medium, more active sites on the particle are exposed for binding.
  • An eighth class of tubes or fibers includes those synthesized by cleaving from a larger block, preferably a disk. The fiber material containing the molecule of interest first is cast as a disk and then a long fiber is peeled from the circumference of a rotating disk.
  • That technology is essentially the same as a smaller version of producing wood veneers where the veneer is peeled from a rotating log.
  • the technique has certain space and handling advantages over a long thin fiber.
  • Such a disk also is more easily stored, particularly when active components therein require maintenance under certain conditions, e.g. freezing, submergence in buffer, in the dark etc.
  • Arrays or parallel fibers may be attached together by many techniques.
  • a preferred one is by vapor sintering.
  • the vapor perhaps a hot solvent, is allowed to interact with the array for a specified period of time and then is removed by evacuation.
  • heat sintering the array is placed under lateral compression and the array heated to the softening point of the plastic.
  • low melting point metals such as gallium.
  • low melting point temperatures at or about physiologic temperature of the binding component.
  • histological embedding media has been developed that preserves biological molecules in reactive form. For example, Durcupan, Nanoplast and
  • a fiber made of such a material could be used to make sections made smaller by heating before or after attachment to a solid phase.
  • the sliced chip may be made as a "macro" array then shrunk down to a "micro" array.
  • the slice may be thicker but have a smaller diameter.
  • the invention may be used for, but not limited to, microarrays of peptides, oligonucleotides, DNA and combinatorial compounds.
  • slow heating is used so that the sliced chip does not crumple into a ball.
  • the heat shrink plastic has good shrink properties at low temperature (for example, see Paleari et al., U.S. Patent No. 6,063,417).
  • the sliced chips are prepared from dehydrated or shrunken fibers.
  • the slice absorbs the water and expands.
  • the material surrounding the fiber or part of the fiber is unaffected and the swollen material will protrude making a raised pad.
  • a polyacrylamide gel may be surrounded by opaque polypropylene (carbon black pigment) and the clear polyacrylamide may form a curved surface.
  • such a surface may act as a lens for, but not limited to, fluorescence, light scattering, chemo- or electroluminescence, color formation and stain detection.
  • the sliced chip may be
  • New PCT combd micro.doc 33 placed in a moisture tight container, perhaps with a desiccant.
  • glycerol, humectants or lubricant may be added so that the sliced chip will maintain flexibility. Such substances may be removed before use.
  • porous chips are placed on a porous solid support.
  • agents of interest or binding partners are forced through the porous array by flow, resulting in diffusion distances in the flow through array in the nm range, reducing rate limiting diffusion/hybridization incubation times.
  • an element of a microarray is formed by mixing a biological reactive molecule with a matrix which is subsequently removed from the element of the microarray, allowing the biological target molecule to then react with a component of a surface with which it is in contact, to provide a stable linkage between biological target molecule and the surface.
  • a protein can be used for this purpose that has a recognition site for another molecule, such as biotin, which can be bound by strepavidin.
  • This biotinylated-protein can be mixed with a reversible gelling system, such as but not limited to, agarose.
  • Cylindrical tubular elements can be formed in which the elements are comprised of the reversible gel containing a biological target molecule.
  • thin sections can be prepared and mounted on a surface that contains immobilized recognition factors, such as in this case strepavidin.
  • the gel can then be dissolved or removed by any means to expose the biological target molecule that is then free to diffuse and react with the immobilized recognition factor.
  • This has the advantage of eliminating the support polymer as a barrier to reactants and can serve to increase the processing time for analyte detection.
  • the recognition system can be comprised of many types of interactions, such as, but not limited to, antigen-antibody, lectin-carbohydrate, and in general, any of the well known ligand receptor systems.
  • Reversible gels can be comprised of, but not limited to heat reversible agar or agarose systems, reversible polyacrylamides, metal dependent alginate systems, redox dependent disulfide containing polymeric systems (e.g., polymers formed by oxidation of sulfhydryl groups to disulfides that can be reduced back to free sulfhydryl groups).
  • the support matrix may be one that can be degraded by any means to liberate the entrapped biological target molecule. The degradation process can consist of, but would not be limited to acid or base hydrolysis,
  • the gel can be dissolved and removed by filtration through the porous support.
  • the biological target molecule would then be retained by the receptor attached to the porous support.
  • the embedding medium is soluble, reversible, degradable or meltable to be removable after the microarray is formed. By removing the embedding medium, the ligand or receptor is available to bind to the solid support. This variation is particularly preferred when the particle is actually microfibers or microbrushes of microfilaments having the immobilized ligands or receptors thereon are sedimentable to the solid surface.
  • the outside of the tubes are cleaned, may be treated with reagents to increase the adherence of the infiltrating supporting plastic, and then bundled to produce the product for sectioning.
  • nucleic acid targets can be detected by, for example, in situ hybridization and amplification of specific sequences by the polymerase chain reaction (PCR) and other nucleic acid amplification techniques (LCR, RCA, SDA etc).
  • PCR polymerase chain reaction
  • the method of embedding is one that preserves the desired characteristic or characteristics of the binding component in a biological cell.
  • the immobilization method will be one which retains the antigen-binding ability of the antibodies.
  • the method and means of attaching the fibers to form the array are also ones, which retain the antigen-binding ability of the antibodies.
  • the immobilizing and attaching method and means are those that retain the configuration of the candidate molecules that allows recognition and binding by the hormone receptor.
  • Detection is generally by incorporation of a fluorescent dye into the analyte or into the second layer of a sandwich assay, or by coupling an enzyme to an analyte or a second or third layer of a sandwich assay that produces an insoluble dye, which may be fluorescent.
  • Some solid phase surfaces may be used directly to immobilize reactants; others must be modified to allow such additions.
  • Antibodies will adhere to clean polystyrene surfaces, as will many other proteins (Van Oss, C. J., & Singer, J.M. The binding of immune globulins and other proteins by polystyrene latex particles. J. Reticuloendothelial Society 3: 29040, 1966.)
  • Polystyrene either in the form of microtiter plates or beads, has been modified to bind biological molecules, such as, polynucleotides, polypeptides and polysaccharides.
  • Perfluorocarbon such as fluorocarbon polymers known as Teflon ®
  • Teflon ® polytefrafluoroethylene
  • PTFE polytefrafluoroethylene
  • polyvinylfluoride polyvinylidene difluoride
  • perfluorodecalin surfaces bind proteins or other biological molecules (U.S. Pat. No. 5,270,193).
  • Such surfaces can be made to include fluorinated surfactants, which may render the surface hydrophilic, or positively or negatively charged.
  • Glass including controlled pore glass, may be modified to allow covalent attachment of antibodies, antigens, polysaccharides, polynucleotides, nucleic acids and the like.
  • Plastic surfaces may be modified non- specifically using corona plasma discharge or electron beam radiation and then may be coated with a variety of coatings or adhesives to which macromolecules may be attached. More specific covalent attachment of biological molecules may be achieved by a variety of modifications, which attach reactive groups to polystyrene, or acrylic surfaces, which groups, with or without extending linkers, then will couple under mild conditions to the biopolymers.
  • the solid phase may be made from glass or silicone, including, but not limited to, nanochannel glass and oriented array microporous silicon.
  • chromatographic media also has been adapted to support immobilized bioreactants.
  • Such media include soft gel beads, generally composed of acrylamide, agarose, Sepharose, which may be chemically cross-linked, and less compressible beads designed for high-pressure chromatography.
  • Soft gel beads generally composed of acrylamide, agarose, Sepharose, which may be chemically cross-linked, and less compressible beads designed for high-pressure chromatography.
  • cellulose which is readily available in powdered form.
  • the supports may be modified chemically to allow covalent bioreactant attachment, or may be purchased in modified form ready for attachment.
  • Long DNA or RNA molecules may be immobilized by being polymerized in a gel and are retained purely by physical entanglement. An example is the retention of DNA in agar or acrylamide gels.
  • other biological molecules such as polypeptides, proteins, polysaccharides or nucleic acids may be linked covalently to long polymers so that, when embedded in a gel, diffusion does not occur and the biological molecule remains available for reaction with soluble reactants. Examples include the attachment of proteins or nucleic acids to polyethylene glycol (so-called PEGylation) or to linear acrylamide chains.
  • a receptor or molecule of interest is immobilized and used to bind an analyte
  • general methods exist for immobilizing members of a class of reactants.
  • protein A or protein G may be immobilized and used subsequently to bind specific immunoglobulins, which in turn will bind specific analytes.
  • a more general approach is built around the strong and specific reaction between other ligands and receptors such as avidin and biotin.
  • Avidin may be immobilized on a solid support or attached to a gel and used to bind antibodies or other reactants to which biotin has been linked covalently. That allows the production of surfaces to which a variety of reactants can be attached readily and quickly (see Savage et al., Avidin-Biotin Chemistry: A Handbook. Pierce Chemical Company, 1992).
  • the detection complex attached to the bound analyte may include a dendritic molecule, including branching DNA, to which is attached many fluorescent dye molecules.
  • fluorescent dyes that bind directly to agents of interest.
  • rare earth metal chelates can be used such as, but not limited to, holmium, europium, terbium, samarium, ytterbium, neodymium and dysprosium.
  • the rare earth metal is europium.
  • heavy metals such as, but not limited to ruthenium can be used.
  • dyes are available commercially from, for example, Molecular Probes, Inc. (i.e., SYPRO® Ruby Protein gel stain and SYPRO® Rose Protein blot stain).
  • Patterns for making dental floss having attached short transverse fibers to give a brush-like configuration may be modified to allow attachment of reactants.
  • Patterns encoding identifying information on strands or fibers may be employed in the form of small linearly arranged dots, hi the development of multifiber endoscopy arrays, methods for checking the array have been developed in which a light beam or raster image is introduced at one end of the fiber bundle in such a manner that the light sequentially illuminates each fiber. The pattern of emitted light exiting the other end then is determined. If identical, no fiber is out of place.
  • the art of detecting bubbles or voids in liquid filled tubing is known and may depend on differences in refraction, light absorption or fluorescence as measured along individual tubes.
  • a microforge can produce glass micropipet tips with sizes of 10-30 ⁇ m.
  • the capillary glass is produced from N-51-A material and has a softening point of 780° C. Tips can be pulled using a microforge (e.g., TPI Microforge at http//www.techproint.com/microforge.htm/) and broken with forceps. Such tips can then be backfilled with oil (or other non-compressible fluid)
  • Microtomes for sectioning tissue blocks which may contain samples ranging from soft tissues to bone, often in blocks of embedding material (e.g. wax), are commercially available, as are a variety of tecliniques and arrangements for attaching sections to glass or plastic slides, for treating the slide automatically to remove some or all of the embedding media, and for systematically exposing the slides to a series of reagents.
  • embedding material e.g. wax
  • Microtomes and other sectioning or cutting instruments capable of cutting assembled bundles of tubes into thin sections, and of maintaining the orientation of the component tubes after sectioning are known. Blade cutting may reduce contamination of binding components between cells of the microarray.
  • the microarrays can be of any thickness as required by the anticipated use thereof. Another determining factor might be the rigidity of the fiber bundles. It is likely the sections will be less than 1 cm in thickness. It is likely the sections will be less than 50 mm in thickness. In one embodiment, the thickness of the sliced fiber (or block) is between about 100 ⁇ m and about 1000 ⁇ m. In a preferred aspect, the thickness of the sliced fiber is less than about 50 ⁇ m. In a more preferred embodiment, the thickness of the sliced fiber is less than about 20 ⁇ m, as will be exemplified in further detail hereinbelow, sections can be on the order of microns in thickness.
  • sections may be attached directly to adhesive surfaces on flexible films or on solid surfaces, such as glass slides. It is also feasible to attach sections (the word “section” is used here in place of "chip") at intervals along a film strip, with others interleaved therebetween. Thus, a set of about a dozen or more sections that are different may be placed in repeating order along the film, and
  • the reagent can be incorporated into a paste or a gel that remains firm or quickly hardens after being extruded onto a solid phase.
  • Materials include, but are not limited to drying oils, conventional paint materials, molten materials which dry or cool to the point of becoming very solid, photo-, UV- or heat polymerizing or crosslinked materials and corresponding deposition treatment.
  • coating a slide with calcium chloride and adding a thickened suspension comprising alginate, which further solidifies as the calcium ions dissolve and diffuse through the paste or gel is envisaged.
  • the binding partner and matrix as a core material are co-extruded as a coaxial outer coating.
  • That method can be improved further by exposing the bound antibody array to a solution containing known subsaturating quantities of each analyte protein in a non-fluorescent form, washing the array, and exposing the array to a test mixture of labeled proteins, thus producing a multiple competition assay.
  • the microarray may have either plural ligands or plural receptors and the analyte may be either plural ligands or plural receptors. Competing elements that bind to either the analytes or the microarray cells may be added.
  • the sample may be labeled and/or the competing element may be labeled and/or the microarray cell may be labeled.
  • the labels may be interacting with each other to make a detectable signal or product, or to quench a signal or product.
  • the number of different combinations is in the dozens and any may be used in the instant invention as well as different combinations for different cells of the microarray assay.
  • the availability of inexpensive microarrays testing for many disease markers simultaneously may provide indications of the severity of the disease and/or its prognosis.
  • the diagnosis and subcategorization of each diagnosis is further enhanced in the present invention by measuring combinations of markers. Additionally, it may unexpectedly be discovered that the patient sample actually has a second disease present or that the disease may involve an additional organ system. Also, the overall health of the patient may simultaneously be measured. When performing one test at a time, as in the prior art, one must first suspect an abnormality in order to request a test for it. With the present invention, it is equally easy to measure 1 marker as 500 markers, which would lead to a qualitative difference in how diseases are diagnosed. Many biochemical analyses require that the analytical procedure have wide dynamic range. Thus, enzyme and immunochemical assays often are done by determining the course of a reaction over a period of time, or by doing multiples
  • a microarray comprises a solid phase having a plurality of structures bound to its surface.
  • the structures comprise an immobilized agent of interest that is available for binding to a target and such a microarray can contain a plurality of different agents of interest in a corresponding plurality of different structures.
  • the structures are permeable to the target and the structures comprise a material that includes, but is not limited to, plastics, gels, glass, sols, colloid suspensions and dextrans. Further, the structures may have hollow inner surfaces. In another embodiment, the structures are impermeable to the target and the target binds to the exterior boundaries of the structure.
  • These structures have three-dimensional form and are more than a single layer of molecules bound on the microarray solid support. These are either formed or carved out from a larger structure.
  • the structures in this embodiment may comprise the solidified contents of a tubular fiber where the outer tube has been degraded or removed leaving behind a microarray having structures resembling small pillars with a gap between them where the tubular material once was.
  • the degradation or removal of the outer tubing may be accomplished by dissolving with a solvent, melting or subliming with heat or chemically degrading.
  • Physical removal of the outer tubing where the solidified contents remain adhered to the solid support may be done by having the solidified contents (but not the tubing) bound to the solid support by physical cleavage with a knife or similar instrument, or by laser, electrical arc or other electromagnetic irradiation to destroy and thereby remove whatever material present between the pillars which remain.
  • the solid support may be precoated with a material, which will adhere the solidified contents but not the tubing, thus permitting easier removal. Also, the material may selectively adhere particles and tiny structures in the sliced fiber section without adhering the solidifying matrix.
  • Other techniques for producing a three dimensional structure include depositing a three dimensional structure directly on the solid support surface. This may involve a preformed structure or a fluid or semi-fluid material which solidifies very quickly before it spreads significantly or forms a few molecule thick layer.
  • the preformed structure may be a long fiber that is cleaved once it adheres to the solid surface thereby depositing the structure. An analogy to the later method is seen in the food art.
  • Chocolate chip cookie dough is semi-solid at the time it is extruded or deposited on the cookie sheet with the dough representing the matrix and the chocolate chips representing the agent of interest.
  • a larger piece of material may be cut and pieces deposited such as the process shown in Figure 8 without having the individual cubes (or other shapes) adhered to each other.
  • Arrays have numerous uses other than determining bioactive properties. Chemical interactions and reactions may be tested as well. Such an assay can, for example, enable testing different reactive chemicals simultaneously against a test substance or material to determine corrosion, electrochemical reaction or other interaction. That is particularly advantageous in the chemical formulations of plural substances such as in cosmetics, paints, lubricants etc. Alternatively, one may assay for desirable interactions between the analyte and all of the molecules of interest in the array.
  • the microarray of the present invention has many other non-microarray uses such as using the resulting surface for affinity chromatography, affinity separations,
  • the present invention also may also coat the surface with materials other than organic chemicals and biological materials.
  • materials other than organic chemicals and biological materials Different metals, anticorrosive coatings, decorative or instructional coatings, coatings for surface plasmon resonance (see U.S. Patent 5,955,729), coatings for SELDI (see U.S. Patent 6,020,208), combinatorial libraries of chemicals, and even coatings for depositing photoresists, electrically conductive coatings etc. such as are used in electronic integrated circuits.
  • sensitivity ligand/receptor binding
  • 41834 New PCT combd micro.doc 44 Fluid also may be drawn through by simply applying a stack of paper towels on the backside of the membrane to draw fluid through the microarray.
  • electrophoretic means a potential is applied across the microarray either across the entire microarray or using single point electrodes located on both sides of a single or group of cells of the microarray.
  • Mechanical means may involve a pump of various configurations to mechanically push or pull fluid through the microarray by providing a pressure differential.
  • porous membrane also has certain advantages in washing the microarray to achieve lower backgrounds. If porous particles or threadlike components are embedded within the fiber, sectioning through the porous particle or threadlike component may make the resulting structure more porous and allow greater surface area contact to both reagents and washing. Etching of an embedding medium or capillary also increases porosity and exposure to the immobilized molecules of interest. If a porous particle is sectioned, preferably twice, larger channels allowing passage that is more fluid may be present. Fibers with sectioned particles may be mounted over permeable membrane supports or over holes in a solid base support. The result allows fluid to pass through the cells of the microarray.
  • the instant invention By using the instant invention, one avoids the difficulties of individually spotting each cell on a solid phase or forming a compound at each cell.
  • the former method is limited by human intervention and apparatus, as well as the ability to measure quantitatively small amounts of liquid.
  • the latter technique is limited by the types of compounds that can be synthesized on the solid phase.
  • Both prior art techniques are expensive and require elaborate automated equipment or tedious labor as each array is produced individually.
  • the instant invention is technically simple and quick where the "batch" is in the thousands to millions of microarrays. The only individual effort required for each microarray is the step of cutting and placement of the sections.
  • Microarrays prepared from sets of stored reagents or by the synthesis of different reactive sequences or compounds on the base chip present difficult problems in quality control. With large arrays, each reagent in final form cannot be separately
  • the agent of interest in the instant invention may comprise a very broad range of chemicals, complexes, biological cells or fractions thereof.
  • Nucleic acids, many proteins, proteins which have been modified or are coated with detergents such as sodium dodecyl sulfate are soluble in organic solvents and a wide range of organic compounds and thus can be incorporated into polymerizing mixtures such as those used to produce plastics.
  • detergents such as sodium dodecyl sulfate
  • Peak fractions from separations such as plant extracts, may be collected simultaneously and used to form a microarray.
  • the microarrays then may be used in a large number of assay systems simultaneously, dramatically reducing the time and effort to screen all of the compounds present for whatever activity one chooses.
  • Different fractions or specific compositions may be used to form a single fiber.
  • Two dimensional electrophoresis gels from serum and other tissue and natural sources produce thousands of different proteins separated on the gel. Each may be removed individually (e.g. cut, eluted etc.) from the gel and used as the molecule of interest to form a single fiber. In such a method, with different bundles being formed from different samples, protein differences between different samples may be readily.
  • the microarray may be used to diagnose a variety of protein-based anomalies.
  • a labeled second antibody to the protein of interest may be used to highlight the cell further.
  • the array may be used to immobilize infectious agents, which have been either stained previously or which, are stained after immobilization.
  • microbes from biological samples e.g. serum or plasma
  • Arrays have been prepared using phage display with inserts from specific genes, using synthetic oligonucleotides, or, to a limited extent, using displayed antigens or antibodies.
  • a population of peptide or antibody display phage may be used where each display phage is used to prepare a single fiber.
  • the phage is large enough so that some portion of each surface molecule will remain embedded in the gel or plastic, while another part will be exposed.
  • the molecule of interest may be bound to the fiber per se, entrapped inside the matrix or bound to a solid phase particle or tiny structure that is in or on the fiber.
  • the phage, recombinant bacteria or other complex biostructure also may be fixed and the contained proteins cross-linked using glutaraldehyde or similar fixative, if desirable.
  • Each fiber may contain a mixture of molecules of interest. For example, during chemical synthesis, a number of isomers are prepared. It is convenient to not separate the isomers before forming a fiber in some circumstances. Likewise, when fractionating a mixture, forming a fiber with a mixture of receptors may be acceptable as total and complete isolation is difficult and time consuming.
  • a filling material to maintain the relative positioning of the fibers along the length of the bundle may be desirable.
  • Various glues and adhesives are known in the art.
  • a filling composition comprising an oil constituent with is a relatively high molecular weight aliphatic hydrocarbon of at least 600, an inorganic constituent and a block copolymer thicken yet reduce the viscosity of the material.
  • An antioxidant also may be included. See, for example, U.S. Pat. No. 5,187,763.
  • the filling material selected is one that maintains the fibers in register, can be cut and does not interfere with any downstream procedures to which the microarray will be exposed.
  • other materials that can be used are polymerizable materials, such as a polyacrylamide.
  • the embedding matrix for the fibers may be black, opaque or otherwise adsorbent to emitted signals of a label to reduce cross talk between the cells in the chip. Additionally, any adhesive between the fibers may contain the same adsorbent material to reduce background between cells of the microarray. Optionally, a specific layer of the material may be placed between the fibers before the bundle is formed. When hollow fibers are used, the opaque material may be incorporated into the hollow fiber shell itself. Arrays may have an entire set of antigens/antibodies etc. in the various cells along with controls to screen blood samples for common blood borne diseases before donated blood is provided for transfusion. Likewise, certain symptoms have a number of common causes that may be screened simultaneously for using arrays. For example, urinary tract infections are common and may be caused by a large number of different bacteria of varying sensitivity to various antibiotics. The simultaneous testing for a number of different factors would save considerable time and expense.
  • the non-specific sites on the chip contributed by the substance of the fiber or filament, the embedding material and essentially everything aside from the binding component of interest may be reacted with a blocking agent, such as
  • Arrays may have two or more identical cells made from different fibers but containing identical binding agents. That provides an internal quality assurance check for the array. Additionally, it is preferred for some of the cells to provide different concentrations of the binding component for quantitative measurement of an analyte. Those provide internal standards for the microarray for both qualitative detection and quantitative detection. For example, a series of cells may contain different concentrations of an antibiotic. When a sample microorganism is contacted with the cells and allowed to incubate, the absence of growth in one cell and the presence of growth in another cell provide an approximate minimal inhibitory concentration. The same can be done for determining minimal bacteriocidal concentrations when stained with a vital dye such as trypan blue or fluorescein acetate. Since a microarray may contain thousands of cells, one can determine the antibiotic sensitivity to numerous antibiotics simultaneously. Quantitative determination of other biological activities with either ligand or receptor immobilized in the gel may be used.
  • the same fiber may be used multiple times in the same microarray. That provides an internal quality control check and improves confidence in the binding assay. That also provides additional quantitative measurements if such an assay is perfonned to improve precision. Blank fibers, fibers with no molecule of interest bound thereto, provide a good negative control and should be used in every microarray.
  • Fibers, capillaries or coaxial two-material filaments are arranged in parallel and then sintered or adhesively bonded to form bundles which are preferably resistant to deformation, and in which each strand or capillary is continuous from one to the other.
  • the positional arrangement of fibers or capillaries should remain the same throughout the bundle.
  • Filaments composed of two different types of material in coaxial formation may be used.
  • the core material is made of a material, which can be dissolved, and the cladding being resistant to the same dissolving conditions. For example, strong alkali is capable of dissolving certain types of glass but not others.
  • the dissolving step may occur before or more preferably after sectioning depending on the materials present.
  • the cladding may be dissolvable and the core resistant leaving isolated "islands" on a microarray attached to a backing sheet.
  • the space left by the dissolving step may remain empty or be filled with a diverse material. Partial dissolving to yield a porous material is also part of the instant invention. Porous materials have increased surface area, which is particularly desirable for binding assays.
  • Particles may also be "chemically sintered" to form a filament, sheet or inside of a capillary. That technique also may be used to adhere different fibers together.
  • a blocking agent may be added to block any remaining active sites or adsorption areas on the particle. If not already done, the beads are packed in a tube or the hollow fiber.
  • a chemically reactive compound which crosslinks or couples either the blocking agent and/or the molecule of interest and/or unreacted sites on the beads then is added and at the locations where the beads touch, chemical adhesion results.
  • the tube or hollow fiber may remain in place or be removed.
  • the molecules of interest in the internal pores of the beads are not touching and thus are not altered significantly.
  • the pores of the beads may be filled with a hydrophilic solution and held by capillary action while the spaces between the beds are filled with a hydrophobic adhesive or setting liquid.
  • a representative example of chemical sintering is to adsorb Protein G on porous beads and then to add a gelatin blocking agent.
  • the resulting beads are filled in a 1 mm plastic tube and then a protein crosslinking agent added, e.g. carbodiimide.
  • a protein crosslinking agent added, e.g. carbodiimide.
  • unreacted reagents are washed free and then any suitable antibody of interest is added thereto to bind to Protein G, thereby forming a fiber suitable for bundling and cleaving to make a microarray.
  • the surfaces of the particles may be biotinylated first and avidin may be used as the crosslinking agent.
  • avidin labeled antibodies instead of adsorbing Protein G to the beads.
  • Another alternative is to use relatively large porous beads and an adhesive or embedding medium to fill the spaces between the beads.
  • Ne PCT combd micro.doc 50 fiber is sectioned, the beads are so large so as to be cleaved, thereby opening up the inside of the beads for the bound molecules of interest to be exposed.
  • Hollow beads or microballoons may be used in lieu of porous beads, as molecules of interest encapsulated therein will be exposed on cleavage of the bead.
  • the concept is the same as sectioning a tissue or embedded cell to expose and visualize intracellular features.
  • a tube first is filled with both beads in dry form, the tube shaken and then fluid is pumped therethrough permitting a reaction to occur thereby forming a solid fiber of beads.
  • the beads may be added first (with or without fluid) and the second set added later so that the beads filter down through the spaces between the larger beads and react accordingly.
  • the reaction between the beads may be through specific binding moieties or of a non-specific binding reaction to form a crosslinking of the beads into a sliceable solid.
  • the second beads may be black to reduce stray light in the fluorescence detection.
  • Such fibers may or may not allow for flow after sintering depending on desired utility.
  • fibers containing beads can be used for solid phase synthesis.
  • a nucleotide/amino acid/sugar/chemical unit is first linked to a bead.
  • the bead is preferably glass or a polymer, must be sinterable, yet allow the fiber to remain porous.
  • a hollow fiber is filled with the beads and the beads are sintered together with heat, chemical, vapor, UV, solutions etc.
  • a polynucleotide binding partner in the fiber In the situation of a polynucleotide binding partner in the fiber, one flows/pumps/uses negative pressure/uses capillary action to percolate reagents through the fiber where the reagent reacts with the nucleotide to produce a dinucleotide. After washing, the process is repeated until a sequence product of desired length is generated.
  • the resulting fibers can be bundled before starting synthesis with a random or patterned addition of different nucleotides to prepare many different binding partners in the fibers. For example, i of each bundle is infused with T and appropriate synthesis reagents, and
  • a pattern of DNA/RNA sequences in the sample may be determined. Such a pattern may be a "fingerprint" for a particular abnormality, even in the absence of acquiring specific sequence info ⁇ nation beforehand.
  • the measurement of many different types of mRNA to generate a sample "transcriptome" by other techniques is known in the art.
  • such in situ solid phase synthesis is equally applicable for generating any other "heteropolymer" for fiber immobilization, hi a related aspect, examples include, but are not limited to, polypeptides, polysaccharides, large numbers of organic chemical monomers which are "mix matched” to generate combinatorial libraries as well as polynucleotides.
  • solid phase peptide synthesis is envisaged. Further, such solid phase synthesis methods for polynucleotides and peptides are well known in the art (e.g., U.S. Patent Nos. 4,816,513 and 4,965,349) and are readily adaptable to bead-fiber immobilization as described in the present invention.
  • the solid phase particles inside a fiber may be chemically sintered together after synthesis of the oligomer/polymer/heteropolymer in situ. If the solid phase particles are labeled with a different specific binding partner such as biotin, then a solution of a corresponding specific binding partner, such as avidin or sfreptavidin may be pumped through the fiber and cause the particles to chemically adhere to each other.
  • a specific binding partner such as biotin
  • the bundle is cut transversely or at an angle into many thin disks and portions are optionally dissolved if desired.
  • the resulting disks may be used as channel plates for the amplification of optical images and light pipes. Regardless of whether rods or fibers are used, the thin disks also may be used as filters because of uniform hole size.
  • Each fiber segment in the sectioned two-dimensional array would contain relatively large numbers of binding components, such as DNA, RNA, or protein molecules.
  • a solution which can erode the plastic surface of the array very slowly, is washed over the surface. That is done at a rate, which will remove any biopolymer molecules that become loose. The wash then is continued, grading into a solution that will not erode the plastic.
  • the array then may be dried and stored until used, or may be used at once.
  • particles on the surface are dissolved, forming a solution and exposing the molecules.
  • each fiber has the molecule of interest in the same form as will be present in the microarray, one can perform a quality control check on the fiber itself rather than using the entire microarray. That is particularly important when the microarray is used for diagnostic purposes. Sampling microarrays from a batch may be a quality control check but it does not actually check the microarrays being sold. By contrast, small slices of the fibers themselves are being used in the instant invention. Assaying the fiber itself represents an actual test of every microarray that has a slice of that fiber as a microarray cell.
  • the fibers may be individually assayed, assayed in ribbons or small groups, or assayed as part of the whole bundle before slicing. Furthermore, by testing one final microarray, one has effectively tested all of the microarrays as the composition of the fiber is the same as that portion of the final product.
  • microarrays of the present invention have the ability to hold biological cells or pieces of tissue at the individual addressable locations of a microarray. This is particularly preferred with cells that can be suspended in a solidifying medium before being pumped into a hollow fiber. This finds particular application for leukemia or lymphoma cells that are naturally suspensable. Microarrays so produced are part of the present invention. Bacteria and other microorganisms may also be likewise used to prepare microarrays for screening candidate compounds for antibiotic properties or specific binding properties, such as from a serum source.
  • the key agent of interest components of the fibers is retained by the fiber by being immobilized therein.
  • Immobilization may be accomplished by a number of techniques, known per se, such as entrapment in a matrix and chemical coupling, perhaps through a linking moiety through an amino, hydroxy, sulfhydryl or carboxyl moiety. Chemically attaching the chemical to a monomer or being used as a monomer to be polymerized also effectively incorporates the component. Binding also may be accomplished by a number of affinity techniques such as protein A or protein G for antibody attachment, ligand/receptor pairs such as biotin-avidin, HTV-
  • Arrays need not be assembled in a single step.
  • Flat arrays consisting of a set of tubes arranged side-by-side may be prepared first, and the end of the array sectioned and tested. The flat arrays then can be attached together with a suitable adhesive to give a three-dimensional bundle.
  • the use of intermediate flat arrays means that those can be prepared and stored, and custom two-dimensional arrays can be prepared by selecting and attaching together different one-dimensional arrays.
  • the stepwise assembly procedure provides inspection at each step, minimizes losses due to errors or low binding efficiency of one rod or tubule, and provides flexibility to assemble new patterns of reactants.
  • FIG. 5 illustrates chip 40 with array elements 41, and with a barcode 42 printed along one border to provide identification and orientation, hi addition, small concentrations of dyes, usually non- fluorescent, may be incorporated into the polymers from which selected tubes are made such that they present a pattern 43 to 44, for example, of one or more numbers, or one or more letters. It is also useful to have a few cells or elements which do incorporate fluorescent dyes and which serve to calibrate the fluorescence measurements. It is further feasible to introduce dyes into the contents of selected tubes to additionally identify them.
  • diagonal line 43-44 further indicates that the horizontal rows of tubes from which the array is assembled, are in the proper order. If tubes in an array are out of alignment giving rise to the loss of one tube or rod in one line, this can be readily observed because the entire pattern will show a
  • the embedding material or adhesive used to hold the tubes in a bundled configuration may be opaque, while the tubes and preferably the contents thereof will conduct light along the entire length.
  • one element at a time at one end of the bundle may be illuminated, and the light detected and related to array position at the other at the other end as shown in Figure 6 where bundle 50 with fibers 51 is illuminated by a cathode ray tube (CRT) 52 generated raster 53 which is focused on the distal end of the bundle by lens 54, and the transmitted light recorded by CCD camera 55.
  • Individual spots 56 yield signals 57 that are detected.
  • CTR cathode ray tube
  • FIG. 7 An arrangement for detection using epifiuorescence is shown diagrammatically in Figure 7 where chip 60 is illuminated by beam 61 generated by lamp 62, which passes through filter 63 to isolate light of a wavelength optimal for exciting fluorescence.
  • a split-beam prism 64 directs the exciting light toward chip 60. The emitted light passes back through the split-beam prism after which the emitted wavelengths are isolated by filter 65 and detected by CCD camera 66.
  • Different systems for detecting fluorescence patterns on chips are known to those skilled in the arts.
  • the choice of dissolving or matrix removing liquid depends entirely on the composition of the matrix and the agent of interest to adhere to the solid surface. The selection is at least as broad as that of the matrixes. It is important that this liquid not adversely affect the agent of interest. Such a liquid is not always needed, such as when the matrix is sublimable or heat degradable/meltable.
  • the inert tubes may be evaporated, blotted, aspirated or if the solid surface is a porous membrane, passed through the porous membrane.
  • the same removal techniques may be used for meltable or other removable matrixes that do not require a solvent.
  • a sheet of adsorbent material 70 is impregnated with a single ligand or receptor. That may be done by dissolving the compound in a solution and then impregnating a sheet of adsorbent paper (e.g. filter paper).
  • a crosslinking agent may be added to attach the receptor to the cellulose base of the paper or other support.
  • the sheets then are stacked together (like a book) with adhesive and optionally an inert sheet (not impregnated, preferably black) as a spacer between each sheet of paper. That forms a book (71).
  • the rest of the process is similar to that shown in Figure 1.
  • Multiple strips (72) from different books are stacked to form a bundle (73) that then is cut transversely to form a microarray (74).
  • An adhesive preferably is added to the ribbons to adhere them.
  • an adhesive may be applied to a solid phase or the end of the bundle and the solid phase adhered to the bundle end before sectioning.
  • films which adsorb protein, such as nylon films, may be used.
  • Inert films such as polyolefm, activated using heterobifunctional photoactivatable crosslinking reagents or simple polyurethane film such as that of Thermedics may be used.
  • the fiber material is preferably glass, metal, plastic or other polymeric material.
  • the dissolvable component may be made of a much wider variety of materials. Each material may be a composite of two or more components.
  • the fibers may act as light pipes or total internal reflection fiber optics to transmit positional alignment and information regarding chemical and biological reactions occurring on the surface.
  • the fiber material preferably is chosen to support
  • Hollow fibers may be used to store cells in fresh, frozen or dried condition.
  • Light and electrons emitted directly or indirectly from a reaction or component inside the fiber, particularly a hollow fiber such as a capillary, may be amplified and easily detected when the fiber material is made of glass or other transparent or translucent material.
  • the fiber material may contain a component to react with, detect or convert into another form, the light, electrons or other chemical components emitting from the components or reactions occurring in the fiber. Detection of chemiluminescent reactions in or on the fiber is a suitable method.
  • Gelling materials used in the present invention may be selected from a large number of such known materials.
  • Polymers such as agarose, gelatin, collagen, xanthene, carrageenan, alginate, or a thermosetting, thermoplastic, chemosetting or UV polymerizing polymer may be used.
  • Non-polymeric gelling materials including waxes and clays may be used.
  • Hydrogels are particularly preferred when a reaction occurring between the agent of interest and an added substance for interrogation requires an aqueous environment.
  • the polymerizing agent or setting agent may be added after the fiber has been cast by submerging the cast in a solution of the agent or passing the agent along the outside of the fiber cast.
  • Hydrogels have many desirable features such as variable gel porosity, ability to bind proteins during or after polymerization, low non-specific binding, transparency, harmless polymerization byproducts, controllable polymerization open time, usable with a variety of solvents and so on. Isocyanate polyurethane liquid prepolymers are preferred.
  • gelling material should be sufficiently inert to not interfere with an interaction between the binding component and an analyte.
  • an agent of interest is extracted into an organic solvent, which is miscible with either a thermosetting plastic mixture, or one that is polymerized chemically or by UV or ionizing radiation. That may be done by coating the agents with detergents or other reagents, which will enhance solubility under the
  • the solvent may be miscible in the gelling material or may be extractable or volatile to render a porous final product.
  • Porous products are particularly preferred with solid filament fibers that are self-supporting.
  • the fibers or the gelling material thereof also may contain a dye or other optical absorber so that only analyte/binding components on the surface of each cell are visualized.
  • a dye or other optical absorber so that only analyte/binding components on the surface of each cell are visualized.
  • Such an improvement reduces the effects of diffusion rates through a gel or porous material that may change with temperature, time, type of carrier liquid, etc.
  • a dye that adsorbs UV or emitted fluorescence will reduce fluorescence from non-surface analyte ⁇ nding component reactions.
  • Different dyes may be incorporated into individual fibers.
  • the solid filaments or capillary tubes comprising the fibers may be adhered to each other by a variety of techniques. If the components are sufficiently heat stable, the fibers may be sintered together.
  • a number of adhesives are known, including cyanoacrylate adhesives.
  • the space between the fibers may be filled completely by adhesive or a monomer, which is polymerized.
  • Thermoplastic and gelling materials also may constitute the adhesive by causing a large number of fibers to be held together in a block.
  • inert materials such as Teflon ® tubes may have the surfaces thereof made reactive with sodium metal in a hydrocarbon solvent to etch the surfaces.
  • Non-chemical means such as passing an electrical current through the fibers to fuse the fibers also may be used.
  • the open ends of the capillaries may be sealed against a flat plate, by pressing a deformable material against the surface, evaporating a plastic (e.g. paralene) on the
  • the two-dimensional array bar can be sectioned using conventional microtomes to form a very large number of slices that can be attached, for example, to glass, metal, or plastic. Alternatively, one may first attach the solid phase material to the end of the bundle before sectioning the bundle.
  • That may be performed by first coating either the end of the fiber bundle or the solid phase with, if necessary, an adhesive such as a cyanoacrylate adhesive or a pre-sectioning or post- sectioning sintering. Dyed fibers would be visible in such arrays to confirm identification and orientation. In addition, the fibers can be dyed in such a manner that a visible pattern is formed if the array is made correctly, and the pattern may include a name or a number.
  • an adhesive such as a cyanoacrylate adhesive or a pre-sectioning or post- sectioning sintering.
  • An advantage of the instant system is that very large numbers of arrays may be cut, and some fraction used for standardization. For example, if a bar 100 cm in length were constructed, and if the bar were cut at 100-micron intervals, then 10,000 arrays would be available. If the sections were 10 microns in thickness, then the number of arrays would be 100,000.
  • the individual fibers were 100 microns in diameter, there would be 100 fibers per ribbon, and 10,000 in a bar of fibers with a cross-sectional area of 1 cm square. If there were 330 per ribbon, then the total number would be 108,900, approximately the number of expressed genes postulated to be present in the human genome.
  • the instant invention is the first array to have such a large number of different cells per unit area on a microarray without the binding agent being covalently attached to the chip. It is preferred for the instant invention to have at least 100, more
  • New PCT combd micro.doc 60 preferably 250, 500, 1,000, 5,000, 10,000, 100,000 or a million or more cells per square centimeter of array. That is a much higher concentration than depositable cells formed by microfluidics in commercial microarrays.
  • the embedding medium may be incompatible with the molecule of interest or use in a binding assay, yet still be useable.
  • an aqueous solution may be used to protect proteins and a low melting point wax used to embed the porous particles.
  • arrays ultimately may be required, and some, especially those developed for the identification of infectious agents, may need to be changed at frequent intervals. Further, new disease-associated alleles will need to be incorporated into new arrays. To fill those requirements and allow changes and additions in arrays, it is important to have individual, stable fiber rolls available, and to have the rolls unambiguously identified. Each roll may be identified by the use of micro-stripes applied at short intervals along the roll. In addition, different tubes may have different colors, and non-fluorescent dyes incorporated into the gels to serve as identifiers, or bar coding, may be printed on individual fibers.
  • the chips of the instant invention can be used to identify infectious agents by identifying characteristic nucleic acid sequences, for example, the chips also can be used for identifying intact bacteria, mycoplasmas, yeast, nanobacteria and viruses using arrays of immobilized specific antibodies.
  • microbanding tubes are particular centrifuge tubes of stepped decreasing diameter from the open end to the closed end of the tube that enable concentration of desired low concentration biological elements in a small volume following appropriate methods of centrifugation. See, for example,
  • microbes from biological samples may be concentrated, stained with a fluorescent nucleic acid stain such as TOTO-1 or YOPRO-1, and then allowed to find matching antibodies on the array. They then may be detected by scanning for fluorescence and identified by position.
  • a fluorescent nucleic acid stain such as TOTO-1 or YOPRO-1
  • the present invention By using the present invention, one avoids the difficulties of individually depositing a different reagent on each cell on a solid phase or synthesizing a different compound at each cell.
  • the former technique is limited by both the possibilities of spilling and mixing reagents and by limitations in the accuracy of measurement of small fluid volumes.
  • many proteins are not stable over a long period of time in solution. If arrays are prepared from multiple liquid reagents, these must all be assayed at intervals to ensure adequate stability. Further complicating the use of proteins in liquids is that different proteins degrade at different rates, which may cause unreproducability with microarrays not stabilized by immobilization and/or drying.
  • the latter technique is limited by the types of different compounds that can be synthesized on a solid phase surface. Both prior art techniques are expensive and require elaborate automated equipment or tedious labor to produce each array individually.
  • the present invention for producing microarrays is technically simple and quick, and the batch size may be in the thousands.
  • additional fibers or ribbons may be added to the bundle as needed before sectioning additional arrays. That allows one to detect and measure newly discovered emerging diseases, new proteins, genes or compounds without recreating a completely new bundle.
  • the invention may be applied in an alternative fashion in which the bundles are stored at user sites, and the arrays sliced as needed. That arrangement may be useful for research purposes where identical arrays are required over the long term, but only a few are required at any one time.
  • the invention also allows different immobilization technologies, different classes of immobilized agents of interest, different classes of analytes and different types of detection methodologies to be employed on the same chip.
  • each channel or cell may be determined accurately by mechanical means. Reference markings on polished edges or other suitable locations further identify each cell in the array. Current commercially available computer driven two-dimensional drives of sufficient accuracy can be used so that each cell may be visualized or tested individually, or material may be added thereto or withdrawn therefrom.
  • Cut surfaces of each plate may be polished so that matching plates may be opposed to each other with little possibility of cross leakage.
  • Surface treatment with a material repellant to the fluid to be eventually located inside each cell further reduces cross leakage.
  • fluorinating (Teflonizing) or silanizing agents repel water thereby generating sufficient surface tension to reduce cross leakage of cells filled with an aqueous solution.
  • the sections After sections have been cut from a bundle, the sections generally are bound to a solid backing to provide structural support and ease of handling.
  • the solid backing is typically a sheet of plastic or metal although other materials may be used.
  • New PCT combd micro.doc 64 attachment generally is done by a permanent adhesive or heat fusion.
  • Individual cells in the array may be detected or visualized by scanning the entire array or portions thereof (e.g. one or a few cells) with a charged coupled device (CCD) or by illuminating one or a few channels at a time, such as by a condenser lens and objective lens. The absorbance and emission of light thus may be detected.
  • An optical fiber bundle aligned and registering with the microarray may be used for optically detecting differences between the cells of the microarray.
  • Detection may be based on a large number of detectable labels including radioactive, enzyme, luminescent, electroluminescence, optically absorbent dye, magnetic, spin-labeled, oxidizers or reducers, chemiluminescence, or indirect labels which interact with a detectable component interacting with the agents of interest in the microarray. Detection may also be accomplished by measuring surface plasmon resonance, see U.S. Patent 5,955,729.
  • a suitable detectable labeling system is based on fluorescence, usually epifluorescence. That requires that the interrogating sample be labeled with one or more fluorescent dyes. The amount of test material required is very small since the dye would be applied to the arrays as a thin dilute film. Hybridization of nucleic acids would be done under conditions of carefully controlled stringency.
  • Different colored inks, dyes and colored materials are particularly well suited as well as detectable components similar to or opposite from the detectable component(s) being detected in other cells.
  • Printing methods with drying inks or plastics, sublimation, solvent containing an ink, or ink-jet printing may be used.
  • the indicia so formed permits better alignment or easily detectable marking when the array is in use. That permits easy optical alignment.
  • the microarray has been used in a binding assay and the ligands are bound to the receptors, in certain instances it may be useful to provide further identification of the ligand. In certain situations, one does not know the entire structure of the ligand from the receptor that specifically binds to it. For example, if the ligand is a cell, a macromolecular complex or a derivatized molecule with the ligand.
  • the substrate can be configured to enable maintaining a charge that would enhance trapping the biological agent of interest at a particular cell (sector).
  • a cell for example, if the agent of interest is a nucleic acid, each cell can be configured to carry a positive charge.
  • a counterelectrode carries the opposite charge. Then, if necessary, a particular medium is placed into the cell and the charges in the electrodes reversed thereby releasing the ligands, in the example, nucleic acids, at that location.
  • the counterelectrode also may be part of or contain appended thereto a micropipette to collect the elements released from the cell, see U.S. Pat. No. 5,434,049.
  • one uses a porous membrane and applies a current on opposite sides of the membrane.
  • the method used for analysis of the eluate may be capillary electrophoresis, mass specfrometry or a second binding assay.
  • the microarray itself may be introduced into a laser-matrix desorption system incorporated into a mass specfrometry system wherein bound molecules are desorbed and analyzed.
  • the microarray may be reused. That reuse process has the advantage of being standardized by multiple controls over time. Additionally, if the receptor is attached to the matrix of the microarray by a cleavable linker, one can isolate the analyte by cleaving the linlcer. Different cells of the microarray may have different linkers or the same linker and subsequent purification may be needed before additional analysis.
  • substrate refers to the glass capillary arrays with “major surfaces” referring to the open ends of the channel plate and "binding reagent” refers to the DNA, protein or antibody (collectively macromolecules), cells/microorganisms/cellular systems or other agent of interest.
  • Antibodies were prepared by affinity purification by reversible binding to the respective immobilized antigens and subsequently immobilized on particulate supports (Poros G, made by PE Biosystems) in an Integral 100Q biochromatography workstation.
  • Each antibody support was made by trapping the antibody on a column of Poros G (commercially available Poros particles pre-coated with protein G, a bacterial protein capable of binding many immunoglobulins by the Fc domain) and subsequently cross-linking the antibody and the protein G with dimethylpimelimidate (following the PE Biosystems protocol) to immobilize the antibody covalently on the Poros particles.
  • Poros G commercially available Poros particles pre-coated with protein G, a bacterial protein capable of binding many immunoglobulins by the Fc domain
  • dimethylpimelimidate followeding the PE Biosystems protocol
  • Such antibody columns can be reused (with an acid elution of bound antigen) more than 100 times in a subtractive mode, and therefore are extremely stable.
  • Each antibody support was characterized to demonstrate specificity for a single antigen. Antibodies directed against human serum albumin (HSA), transferrin (Tf), and haptoglobin (Hp) were used.
  • a mixture of the three supports was made for use in serum subtraction.
  • a total of three supports were used in tests with: 1) rabbit anti HSA, 2) rabbit anti-human Tf and rabbit anti-human Hp and 3) mixed anti-HS A, Tf and Hp.
  • Unmodified BA Poros commercially available sfreptavidin coated Poros
  • a total of four supports were used. Poros particles are roughly spherical and highly reticulated (with many
  • Each of the four types of antibody-bearing particles was mixed with an approximately equal volume of 0.75% agarose melted in phosphate-buffered saline (PBS).
  • the agarose for the rabbit anti-HSA beads contained green food coloring.
  • the anti-Tf and Hp agarose were colored blue, the mixed anti-HSA, Tf and Hp agarose was colored yellow and the Poros BA containing agarose was white (uncolored).
  • Each melted agarose/bead combination was sucked into a length of one mm diameter plastic tubing of 10 cm in length attached to a 1 ml syringe and plunged in ice water.
  • the four rods thus obtained (each containing one of the four bead types above with a different protein coating) were laid into an aluminum channel with more melted agarose to form an array of 2x2 parallel rods embedded in a square cross-section bar of agarose.
  • the gel was removed from the aluminum channel mold, and transverse sections were prepared by slicing thin slices perpendicular to the axis of the bar (and the filaments) and mounted on a glass slide. The sections revealed a pattern of 4 circular areas (the filaments) containing embedded particulate material (carrying immobilized protein) surrounded by clear embedding matrix of agarose by microscopy. The circular zones of embedded beads were more stable and did not split.
  • HSA and Tf protein were labeled with fluorescein isothiocyanate (FITC) on Cellite (from Sigma).
  • FITC fluorescein isothiocyanate
  • Cellite is a commercial carrier for insoluble FITC.
  • the proteins were dissolved in about 4 ml of 0.4M sodium bicarbonate buffer ( ⁇ pH 8.3) and added to the dry FITC on Cellite in the
  • the reaction was conducted at room temperature for 30 minutes.
  • the Cellite was removed by centrifugation, and the supernatant protein and unreacted dye placed in a centrifugal protein concentrator, where the protein was washed by repeated dilution and re-concentration in buffer.
  • the fluid was centrifuged to remove the
  • the sections were examined under an epifluorescence microscope equipped with a 500 nm low pass filter and a 510 nm high pass filter for fluorescein fluorescence detection and a 35 mm camera.
  • the sections then were washed extensively in PBS and reexamined under the fluorescence microscope.
  • EXAMPLE 2 FORMATION AND ANALYSIS OF A MICROARRAY USING REMOVABLE MATRIX
  • the solid phase i.e., supporting surface for chip/antibody deposition
  • trapping protein G a bacterial protein capable of binding many immunoglobulins by their Fc domain
  • EDC EDC
  • NHS N-hydroxysuccinimide
  • Antibody containing fibers are prepared by mixing at 50°C the antiserum solution preparation with matrix in approximately the ratios of 65% antibody containing PBS, 12 % stearoxymethylsilane, 10% propylene glycol, 7% stearyl alcohol, 2% hydro genated castor oil (castor wax), 1.5% PEG-4 castor oil, 1.5% PPG-5 ceteth-20, and 1% Ceteareth-20.
  • the solution for the rabbit anti-HSA is modified to contain green food coloring to distinguish it.
  • the anti-Tf and Hp are colored blue, the mixed anti-HSA, Tf and Hp is colored yellow and the non-antibody containing control was white (uncolored).
  • Each melted combination is sucked into a length of one mm diameter plastic tubing of 10 cm in length attached to a 1 ml syringe and plunged in ice water. The fiber is allowed to gel into a soft solid.
  • the rods thus obtained are laid into an aluminum channel with ImmunoBed (polymethacrylate) to form an array of 2x2 parallel rods embedded in a square cross-section bar of ImmunoBed.
  • transverse sections are prepared by slicing thin slices perpendicular to the axis of the bar (and the filaments) and mounted on a glass slide. These sections revealed a pattern of 4 circular areas (the fibers) surrounded by clear embedding matrix by microscopy.
  • the reaction is conducted ' under conditions to allow for maximal conjugation.
  • the Cellite is removed by centrifugation, and the supernatant protein and unreacted dye placed in a centrifugal protein concentrator, where the protein is washed by repeated dilution and re-concentration in buffer.
  • the fluid is centrifuged to remove the Cellite and supernatant recentrifuged with 4 ml sodium bicarbonate buffer until clear.
  • the addresses are exposed to a solution of fluorescently labeled HSA.
  • the microarray is then washed extensively in PBS, and re-examined under an epifluorescence microscope equipped with a 500 nm low pass filter and a 510 nm high pass filter for fluorescein fluorescence detection and a 35mm camera.
  • EXAMPLE 3 MANUFACTURE AND USE OF DIAGNOSTIC ARRAY DETECTING AUTOANTIBODIES TO MITOCHONDRIAL OR LYSOSOMAL PROTEINS Suspensions of whole isolated rat and mouse liver mitochondria, lysosomes and expressed proteins are suspended or dissolved in an aqueous buffer, at 10 mg/ml concentration, and optionally fixed with glutaraldehyde (1%).
  • One ml of each preparation is mixed according to the kit instructions with 20 ml of JB-4 (Polysciences) catalyzed infiltration resin prepared by mixing 20 ml of monomer A containing 0.17 g of catalyst. After complete mixing, 40 ml of monomer B containing 0.17 g catalyst is added with stirring. When completely dissolved, 0.8 g of
  • Tests for autoantibodies are done by placing 0.25 ml of a 1 : 10 dilution of human serum on each chip and incubating the arrays at 25°C for 20 minutes. The arrays then are rinsed in phosphate buffered saline four times, and then are immersed in a solution of goat anti-human globulin conjugated with horseradish peroxidase. After a further 20 minute incubation, the arrays again are washed four times with buffer, and then placed in a solution of 3,3',5,5'-tetramethylbenzidine in an organic base to which is added a hydrogen peroxide solution (0.02%) in a citric acid buffer. An insoluble blue color indicates the presence of autoantibodies.
  • EXAMPLE 4 MANUFACTURE AND USE OF DIAGNOSTIC ARRAY DETECTING AUTOANTIBODIES TO MITOCHONDRIAL OR LYSOSOMAL PROTEINS USING REMOVABLE MATRIX
  • Suspensions of whole isolated rat and mouse liver mitochondria, lysosomes, and expressed proteins are suspended or dissolved in an aqueous buffer, at 10 mg/ml concentration, and optionally fixed with glutaraldehyde (1%). 1ml of each preparation is mixed with low temperature gelling agarose. The mixture is placed in a syringe and injected into 0.0625 inch internal diameter Teflon tubing under anaerobic conditions. The ends of the tubes are then heat sealed and stored cold until used, or are immediately
  • Bundles are prepared by laying 10 or more fibers in parallel, to make a single-layered array, in an elongated Teflon box. JB-4 resin without protein is then poured in, the box briefly evacuated to remove air bubbles, and the resin allowed to set. Several such flat arrays may then be stacked in parallel to make a three-dimensional groupings, and the whole grouping further vacuum impregnated to form a three-dimensional bundle. After polymerization, the bundle is cut with a glass microtome knife to give sections 5-20 microns thick, and the sections placed on glass slide. The sections are mounted on EDC/NHS (as the heterobifunctional linking agent) activated glass slides. Microarrays are made by melting and processing as described in
  • Example 1 the solid phase comprises the moiety in Thust et al. U.S. Patent No. 5,955,335.
  • gelling matrix is inert with respect to the heterobifunctional moiety, and after melting, the immobilized biomaterials are allowed to interact with the solid phase surface. The matrix is removed as described in Example 1.
  • Tests for autoantibodies are done by placing 0.25 mL of a 1:10 dilution of human serum at each address and incubating the arrays at 25°C for 20 minutes. The arrays are then rinsed in phosphate buffered saline four times, and are then immersed in a solution of goat anti-human globulin conjugated with horseradish peroxidase. After a further 20 minute incubation, the arrays are again washed four times with buffer, and then placed in a solution of 3,3', 5,5'-tetramethylbenzidine in an organic base to which is added a hydrogen peroxide solution (0.02%) in a citric acid buffer. An insoluble blue color indicates the presence of autoantibodies.
  • EXAMPLE 5 MANUFACTURE AND USE OF A DIAGNOSTIC ARRAY USING HISTOLOGICAL EMBEDDING SUPPORT
  • Arrays are prepared which incorporate fixed infectious particles to be used to detect convalescent antibodies appearing late in the history of an infection. That is important in following sentinel populations to determine what infections are occurring.
  • hnmuno-Bed GMA water-miscible embedding medium is made up as directed
  • the arrays are assembled in bundles using jigs to hold the fibers in parallel array, after which the array is infiltrated with an epoxy resin.
  • the finished bundle which includes sections of Teflon ® tubing, is sectioned and the sections mounted on glass slides using an epoxy resin mounting medium. The sections are washed for rehydration and then are exposed to convalescent antisera. The chips then are extensively washed and exposed to goat anti-human IgG with the covalently attached fluorescent dye fluorescein. Identification of convalescent antibodies is done by detecting and measuring fluorescence using a CCD camera.
  • EXAMPLE 6 MANUFACTURE OF DIAGNOSTIC ARRAY USING SINTERED STRIPS
  • Sintered polystyrene sheets 1/16 inch thick are cut into square cross-section strips and each exposed to dilute solutions of one monoclonal antibody to a series of infectious agents including viruses such as rhinoviruses, herpes simplex viruses, influenza virus type A, respiratory syncytial virus, varicella-zoster virus (chickenpox), mycobacterium tuberculosis, cytomegalovirus, Epstein-Barr virus, Hepatitis B Virus (surface antigen and separately core antigen) poliovirus (three strains) and others.
  • the strips are rinsed, dried and glued together with an acrylonitrile adhesive to form a three-dimensional array that is sectioned to produce arrays 5-100 microns thick.
  • Biological samples containing infectious viruses from individuals with viral diseases are fluorescently stained with the nucleic-acid specific dye YOYO-1 (Molecular Probes) and isolated and concentrated using centrifugal microbanding, see WO99/46047 supra, to concentrate the infectious particles into microliter volumes.
  • the concentrated viruses are applied to the array and are agitated mechanically to
  • 41834 ewPCT combd icro.doc 74 move the virus particles over the array for one hour.
  • the array then is washed, excess fluid removed by suction and illuminated with ultraviolet light at 490 nm.
  • the image is captured with an Apogee CCD camera using a 520 nm filter. Quantitative data is obtained from the processed image using the PMIS image analysis program.
  • EXAMPLE 7 MANUFACTURE AND USE OF DIAGNOSTIC ARRAY HAVING IMMOBILIZED OLIGONUCLEOTIDES:
  • Polystyrene beads (10-50 microns in diameter) from solid phase oligonucleotide synthesis with oligonucleotides covalently attached are suspended in buffer and packed into hollow glass fibers of 500 microns internal diameter under hydrostatic pressure initially and then under air pressure up to 500 psi to expel the supporting liquid. The fiber then is heated briefly under controlled conditions to partially sinter the contents.
  • An array of fibers then is prepared following the methods in the,, examples above, embedded in a low viscosity epoxy resin with intermittent vacuum to remove air bubbles and then allowed to set. The bundle is sectioned using a diamond saw. The array is used in a flowthrough arrangement so that the materials thereon can be manipulated in a fashion similar to that conducted with larger multiwell microtiter plates as described in U.S. Pat. No. 5,843,767, supra.
  • GCA glass capillary arrays
  • GCA Glass capillary arrays
  • the GCA has approximately 50% of the area composed of 50 ⁇ holes or approximately 156,000 holes having a total volume of approximately 0.1 ml.
  • the bottom surface of the GCA is glued to a Teflon ® sheet with cyanoacrylate adhesive (SUPERGLUE).
  • a colony of Streptococcus pyrogenes Group A and a colony of Group B were picked from a plate and mixed together in nutrient agar forming a suspension of the bacterial cells (other microorganisms, animal or plant cells are equally applicable) and
  • 41834NewPCT combd rnicro.doc 75 are diluted to an approximate concentration of 20,000 cells/ml of culture medium. About 0.1 ml of the suspension is applied to the surface of the GCA. That yields about 1 cell per 100 holes to ensure only single cell clones result.
  • the GCA is placed in a sterile petri dish, covered and incubated overnight at 37° C. Two additional sterile GCA's without a Teflon ® sheet on the bottom are filled with 0.1 ml heated liquid culture fluid supplemented with 1% agarose, cooled until almost solidified and stacked directly on top of the GCA having cloned bacterial cells so that the holes from each GCA are in register.
  • a top sheet of Teflon ® is pressed on tightly and the stack is clamped together. The entire stack is turned upside down and incubated for five minutes at room temperature. The entire stack is turned sideways and incubated overnight at 37° C. The stack then is turned upright, unclasped and individual GCA's are separated. The original GCA is retained for further use.
  • Each of the two added GCA's is placed in a glass flask, attached to a lyophilizer and vacuum dried for 1 hour.
  • the GCA's are removed and 0.1 ml of FITC conjugated antibody to Sfreptococcus Group A (DIFCO) is added to each GCA and incubated at room temperature for 10 minutes.
  • Each GCA then is blotted on an adsorbent tissue (KIMWIPE) to remove fluid.
  • KIMWIPE adsorbent tissue
  • the microarray is washed by submersion in PBS and blotted dry again.
  • the fluorescent holes in the GCA's and bacteria containing holes in the original GCA are detected using a CCD scanner which gives 12.5 ⁇ pixels and is capable of a resolution of 25 ⁇ needed to detect holes which contain cell clones.
  • the scanner is first set to scan for fluorescence and then for absorbance to detect the presence of bacterial clones.
  • Absorbance is used to indicate presence of bacteria to align the holes of the two GCA's. Fluorescence is detected in some but not all of the holes containing bacterial clones in the original GCA and correspond to presence of Group S bacteria.
  • EXAMPLE 10 SELECTING MONOCLONAL ANTIBODIES Monoclonal antibody-secreting hybridomas in suspension are diluted to approximately 20,000 cells/ml RPMI 1640 + 5% fetal bovine serum culture solution
  • Human serum proteins are separated by 2-dimensional electrophoresis as per Baekkeskov et al, Diabetes 38(9): 1133-41 (1989). Two hundred spots are punched from the gel and the individual proteins dialyzed in 1 ml of PBS.
  • One ml of the protein solutions is mixed with 40 mg of acrylamide monomer with catalyst and pumped into 1 mm internal diameter, one meter long polypropylene tubes, the ends heat sealed and each tube tagged.
  • a number of control tubes are prepared with various dyes for easy identification of the correct orientation of the microarray when formed.
  • the acrylamide is allowed to polymerize overnight.
  • the tubes are aligned in a bracket and glued between rows as above. The bundle is cut by a microtome under freezing conditions into 10 micrometer thick slices and the microarray is immediately fixed on a plastic sheet.
  • Mouse monoclonal antibodies to the following antigens are individually contacted to a separate microarray, incubated, washed, dried and followed by contacting with FITC-conjugated (fluorescein-labeled) goat anti-mouse IgG and scanned as in EXAMPLE 8 above.
  • Insulin, calcitonin, glucagon, epidermal growth factor, interferon, CEA, prostatic acid phosphatase and human IgG are among the common antigens tested. Both hormone levels and tumor antigen levels are determined in a semi-quantitative manner.
  • Microarrays are prepared in accordance with EXAMPLE 2 except for filling each tube with nutrient agar mixed with various antibiotics in the following ' configuration. Five two-fold dilutions across the effective spectrum of useful concentrations of the antibiotics, erythromycin, penicillin V, tefracycline, ampicillin, trimethoprim sulfamethiozole, cefaclor, ofloxacin and nitrofurantonin and 10 two-fold dilutions of 34 new compounds, each a candidate for use as an antibiotic are used.
  • a colony of an unknown sample of E. coli grown from urine of a patient was suspended in 1 ml nutrient broth supplemented with either fluorescein acetate or trypan blue and placed on each of two microairays and incubated at 37 ° C.
  • the microarray is scanned for fluorescence and for absorbance at the beginning and after 30 minutes incubation.
  • Microarray cells with detectable increases in fluorescence were considered to have growing cells.
  • Microarray cells with increases in trypan blue absorbance from the beginning to 30 minutes were considered to have dead cells.
  • Minimal inhibitory concentrations (MIC's) and minimal bactericidal concentrations (MBC's) thus were determined. The possible effectiveness of the new candidate compounds likewise was deduced.
  • MIC's were determined the next day based on the diameter of the zone of inhibition.
  • the MIC's from the microarray are comparable to standardized growth inhibition measurements. For example, for nitrofurantonin, the zone diameter from a 300 meg disk in millimeters is >17 mm susceptible, 15-16 mm intermediate and ⁇ 14 mm resistant which corresponds to a MIC in mcg/ml of ⁇ 32, 64 and >128 respectively. Two-fold dilutions of nitrofurantonin in the microarray are at 16, 32, 64, 128 and 256 mcg/ml.
  • Microarrays are prepared according to the method in EXAMPLE 2 with suspensions of various fresh cells from a leukemia patient, several leukemia cell lines (HTB, ATCC), normal peripheral white blood cells and normal bone marrow cells.
  • the microarrays are treated by an alkaline-lysing and protease K-digesting reagent, heat denatured and a digoxigenin-labeled DNA probe for the following genes: N-myc, C-myc, K-ras, p53, HER-2/neu and a candidate DNA probe for diagnostic purposes, are applied thereto.
  • Texas Red-labeled anti-digoxigenin antibody is added and the pattern and amount of binding are determined.
  • EXAMPLE 14 ANTICANCER DIAGNOSTIC AND DRUG SCREENING USING REMOVABLE MATRIX.
  • Suspensions of various fresh cells from a leukemia patient, several leukemia cell lines (HTB, ATCC), normal peripheral white blood cells and normal bone marrow cells in PBS With 2% sodium alginate are prepared.
  • a commercial dialysis hollow fiber membrane is cut in half and the hollow fibers spread apart. Individual hollow fibers are added 2 ml tubes of each cell suspension. The fluid is draw through each fiber by aspiration. The ends are heat sealed and the apparatus submerged in 1% calcium chloride in saline solution for ten minutes to permit diffusion of calcium ions.
  • the end block of the hollow fiber dialysis apparatus is sectioned transversely by a microtome at 10 microns thick. Thin section slices are placed on a porous nylon membrane.
  • a piece of filter paper is saturated with 5 g/1 sodium EDTA solution, placed in a humidified chamber and the nylon membrane placed on top and incubated for one hour.
  • the nylon membrane is removed, washed and the section slices removed to form a microarray.
  • the cells attached to the nylon are alkaline-lysed and protease K-digested by standard procedures for in situ hybridization.
  • the microarrays are heat denatured and a digoxigenin-labeled DNA probe for the following genes: N-myc, C-myc, K-ras, p53, HER-2/neu and a candidate DNA probe for diagnostic purposes are applied thereto.
  • Texas Red-labeled anti-digoxigenin antibody is added and the pattern and amount of binding are determined by fluorescent microscopy.
  • a membrane of PVDF is used as the solid surface to form a microarray.
  • a 5% acrylamide protein containing buffer solution is prepared for HSA, haptoglobin and transferring and sucked into a 1 mm diameter plastic tube as in Example 1 and polymerized. The remainder of the sliced section preparation process of Example 1 is repeated.
  • the entire setup is placed in an electrophoresis system, submerged in buffer and the protein ' electrophoresed to the membrane. After removal, the sliced section is physically removed the microarray washed.
  • Fluorescently labeled antibody preparations (labeled as above) to each of the proteins are applied to separate microarrays and the results observed by epifluorescence microscopy.
  • a microarray is prepared as in EXAMPLE 2 except that ten, 2- fold dilutions of mouse monoclonal antibodies to HAV, HBsAg, HBcAg, HCV, HDV and HEV and 2-fold dilutions of the same antigens are used. Three tubes of each are prepared and used in the microarray along with a pattern of controls. Approximately three drops of serum sample is contacted with the microarray, incubated in a 37° C water bath for 10 minutes and washed four times with PBS.
  • microarray About 1 ml of a reagent of fluorescein-labeled monoclonal antibodies to non-overlapping epitopes of each of the antigens, fluorescein-labeled mouse anti-human IgG and rhodamine-labeled mouse anti-human IgM is added to the microarray, incubated for 10 minutes in a 37 ° C water bath and washed four times with PBS. The microarray is scanned for fluorescence at both the wavelength of fluorescein and rhodamine emissions and the results determined for which cells of the microarray demonstrate fluorescence, the wavelength of light and the level thereof. The microarray is designed for both initial diagnosis and for monitoring treatment and remission by detecting antigens and antibodies in convalescent serum.
  • EXAMPLE 17 SCREENING ACTIVE COMPOUND CANDIDATES Microarrays are prepared according to EXAMPLE 2 except 380 new candidate compounds are introduced into the fibers. Three drops of a solution containing the glutamate receptor 2 are added to the microarray followed by incubation at 37° C for 10 minutes. The microarray is washed and dried as before. A 1:10 dilution of mouse monoclonal antibody to glutamate receptor 2 (Vector Labs) is added, incubated, washed and dried as before. FITC-conjugated goat anti-mouse IgG is added and the microarray scanned.
  • Fluorescent cells correspond to compounds that bind to the receptor. Since the receptor is involved in learning, memory, seizures and other neurological conditions, by binding the neurotransmitter glutamate, both agonists and antagonists are of pharmacological interest.
  • EXAMPLE 18 FORMATION AND ANALYSIS OF A MICROARRAY BY FLUORESCENCE
  • a microarray was prepared from cylindrical polymethacrylate fibers containing a) microbeads with immobilized antibodies to rat IgG, b) microbeads with immobilized antibodies to human IgG and c) no microbeads as a control.
  • the array was formed by aligning the fibers in parallel along the long axis, sectioning with a microtome, then transferring the sections to glass slides. The slides there were tested in a fluorescent immunoassay to demonstrate specific protein binding to the beads as follows:
  • the embedding material used was ImmunoBed (Polysciences, Inc., Warrington, PA) prepared according to the directions of the manufacturer. Dry catalyst (225 mg) was dissolved in 25 ml of ImmunoBed Solution A. To that solution was added 1 ml of ImmunoBed Solution B. The mixture was kept cold and then introduced into a four foot length of Teflon tubing (1/32 inch ID) using a syringe attached to the tubing. The tubing filled with hnmunoBed resin was allowed to stand undisturbed overnight at room temperature. The polymerized fiber could be removed from the Teflon tubing by trimming the end of the tubing with a single edge razor blade to expose the fiber, then gently pulling the fiber from the tubing.
  • UltraLink beads containing antibodies to human IgG and rat IgG were prepared as described above. About 0.5 ml of each were collected by centrifugation at 2000 rpm for 10 minutes then mixed with 5 ml of cold ImmunoBed solution (Solution A + catalyst + Solution B) prepared as described above. The beads then were centrifuged for 10 minutes at 2000 rpm at 5°C. That was repeated three times. The pelleted beads then were resuspended in 1 ml of the ImmunoBed solution and drawn into 1/32 inch ID Teflon tubing. The tubing was folded into a bundle, placed in a centrifuge bucket and then centrifuged for 10 minutes at 2500 rpm. The buckets were removed and left overnight at room temperature to allow the ImmunoBed to polymerize. The bundles were cut into sections by cutting the top end of the folds and the strands were extruded.
  • the 10-micron section prepared above and mounted on a glass slide was treated with 100 ⁇ l of normal rat serum (IgG containing), diluted 1 :50 with PBS containing 1 mg/ml BSA, for 60 minutes at room temperature.
  • the solution was drained from the slide, rinsed 1 time with 100 ⁇ l PBS/BSA, then washed three times with 100 ⁇ l PBS/BSA for 5 minutes before draining. After the last wash, 100 ⁇ l of R- Phycoerythrin-labeled affinity purified goat antibody to rat IgG (H+L) (Kirkegaard and Perry, Gaithersburg, MD), diluted 1:100 with PBS/BSA were added and allowed to stand for 60 minutes at room temperature.
  • the solution then was drained and washed 4 times as before. After fluorescent immunostaining, the section was viewed in an Olympus Model BX-40 fluorescent microscope (Olympus America, Inc., Melville, N.Y.) using a green filter (exciter filter 510-550 nm, barrier filter 590 nm).
  • the four circular slices that comprised the 10-micron slice included 2 control slices, one slice containing beads with anti-human IgG and one slice containing beads with anti-rat IgG.
  • the circular slice containing antibody to rat IgG was more highly fluorescent than the slice that contained anti-human IgG, and the 2 control slices, thus demonstrating the specificity of the reaction. Table of Data
  • Antibodies are prepared by affinity purification by reversible binding to the respective immobilized antigens and subsequently immobilized on particulate supports (Poros G, made by PE Biosystems) in an hitegral 100Q biochromatography workstation.
  • Each antibody support is made by trapping the antibody on a column of Poros G (commercially available Poros particles pre-coated with protein G, a bacterial protein capable of binding many immunoglobulins by the Fc domain) and subsequently cross-linking the antibody and the protein G with dimethylpimehmidate (following the PE Biosystems protocol) to immobilize the antibody covalently on the Poros particles.
  • Poros G commercially available Poros particles pre-coated with protein G, a bacterial protein capable of binding many immunoglobulins by the Fc domain
  • dimethylpimehmidate followeding the PE Biosystems protocol
  • HSA human serum albumin
  • Tf transferrin
  • Hp haptoglobin
  • a mixture of the three supports is made for use in serum subtraction.
  • a total of three supports are used in tests with: 1) rabbit anti HSA, 2) rabbit anti-human Tf and rabbit anti-human Hp and 3) mixed anti-HSA Tf and Hp.
  • Umnodified BA Poros commercially available sfreptavidin coated Poros, is used as a non-antibody confrol. Thus, a total of four supports were used.
  • Poros particles are roughly spherical and highly reticulated (with many internal crevices), having a diameter of approximately 5 microns. Attached proteins are distributed over the internal surfaces as well as the exterior surface of the particle. By embedding the particles in a suitable medium, a sliceable solid matrix in which the antibody is immobilized and fairly uniformly distributed is created. By exploiting the 3-dimensional nature of the support, a slice containing such particles offers greater capacity (for antibody and thus for antigen binding) than a simple flat surface as used in current microarrays.
  • Each of the four types of antibody-bearing particles is mixed with an approximately equal volume of 0.75% agarose melted in phosphate-buffered saline
  • the agarose for the rabbit anti-HSA beads contained green food coloring.
  • the anti-Tf and Hp agarose are colored blue, the mixed anti-HSA, Tf and Hp agarose is colored yellow and the Poros BA containing agarose is white (uncolored).
  • Each melted agarose/bead combination is introduced into a length of one mm diameter plastic tubing of 10 cm in length attached to a 1 ml syringe and plunged in ice water. In several minutes, the agarose gels into a jelly-like rod containing approximately 50% Poros beads by volume.
  • the four rods thus obtained are laid into an aluminum channel with melted agarose to form an array of 2x2 parallel rods embedded in a square cross-section bar of agarose.
  • the gel is removed from the aluminum channel mold and transverse sections are prepared by cutting thin slices perpendicular to the axis of the bar (and the filaments) and the slices are mounted on a glass slide.
  • the sections revealed by microscopy a pattern of 4 circular areas (the filaments) containing embedded particulate material (carrying immobilized protein) surrounded by clear embedding matrix of agarose.
  • the circular zones of embedded beads are stable.
  • HSA and Tf protein are labeled with either europium chelate or ruthenium chelate using either SYPRO RUBY or SYPRO ROSE protein stain as directed by the manufacturer (Molecular Probes Inc., Eugene, OR).
  • Sections of the 4-filament array are laid flat on a glass microscope slide and exposed to a solution of rare earth/heavy metal chelate labeled HSA. Dxiring the exposure of the section, the protein is expected to interact specifically with the antibodies present on two filaments (round areas on the section): the two filaments are those bearing antibodies to HSA and the mixture of anti-HSA, Tf and Hp. Labeled HSA is not expected to interact with the filaments carrying antibodies to Tf alone or to the filament carrying sfreptavidin alone.
  • the sections are examined under an epifluorescence microscope equipped with a 490 nm long pass filter or 600 nm bandpass filter for fluorescence visualization and a 35 mm camera or CCD camera. Excitation is carried out at 300 to 310 nm.
  • EXAMPLE 20 IN SITU SOLID PHASE SYNTHESIS OF POLYPEPTIDES Briefly, polystyrene beads (10-50 microns in diameter) from solid phase polypeptide synthesis with single amino acids covalently attached are suspended in buffer and packed into hollow glass fibers of 500 microns internal diameter under hydrostatic pressure initially and then under air pressure up to 500 psi to expel the supporting liquid. The fiber then is heated briefly under controlled conditions to partially sinter the contents. A solution for the amino acid subunits in a suitable solvent (e.g., N-methylpyrrolidine (NMP), dimethyl formamide (DMF), dichloromethane (methylene chloride) or chloroform) is mixed with the particles.
  • NMP N-methylpyrrolidine
  • DMF dimethyl formamide
  • dichloromethane methylene chloride
  • chloroform dichloromethane
  • the subunits are preferably N-protected amino acids, typically one of the 20 naturally occurring L-amino acids having protected ⁇ -amine groups, and protected carboxy, hydroxy, thiol and amine side chain groups.
  • the subunit molecules infiltrate the matrices of particles until substantially all of the subunits are entrapped in (or associated with) the particles.
  • N- ⁇ -protected amino acids are added to synthesize the peptide in 9-fluorenylmethoxycarbonyl (Fmoc) solvated in DMF.
  • Activated forms of the amino acids can be added as symmetrical anhydrides, pentafluorophenyl esters and l-oxo-2-hydroxydihydrobenzotriazine active esters.
  • activating agents may be added to the polymer composition with the solvent.
  • a useful activating agent for Fmoc-based synthesis is hydroxy-O-benzotriazole, tetramethyluronium hexafluorophosphate (HBTU), to which is added hydroxy-O-benzotriazole (HOBT) and diiospropylethylamine (DIEA).
  • HBTU tetramethyluronium hexafluorophosphate
  • DIEA diiospropylethylamine
  • dimethylformamide (DMF)/N-methyl-pyrrolidone (NMP)/dimethylsulfoxide (DMSO) can be used.
  • the Fmoc protection group is first removed with piperidine and DNF, with the piperidine being thoroughly removed before addition of the next residue.
  • a solution of HBTU, HOBT, DMSO, NMP and DIEA is mixed with the Fmoc amino acid to
  • New PCT combd micro.doc 86 activate the amino acid to form a derivative which will react with the ⁇ -amino group of the growing peptide chain immobilized on the fiber.
  • the fiber is then washed with DMF and the mixture containing the activated amino acid is flowed through the fiber to couple the amino acid subunit to the growing peptide chain.
  • the Fmoc protection group is removed and the above procedure is repeated for subsequent amino acids until the planned peptide is complete.
  • An array of fibers then is prepared following the methods in the examples above, embedded in a low viscosity epoxy resin with intermittent vacuum to remove air bubbles and then allowed to set.
  • the bundle is sectioned using a diamond saw.
  • the array is used in a flowthrough arrangement so that the materials thereon can be manipulated in a fashion similar to that conducted with larger multiwell microtiter plates as described in U.S. Pat. No. 5,843,767, supra.
  • dialyzer cartridge Also, use of dialyzer cartridge by filling hollow fibers and embed protein in fibers as they are formed before the cartridges are cut.

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

L'invention concerne des microréseaux préparés par l'utilisation d'une fibre séparée pour chaque composé utilisé dans le microréseau. Les fibres sont mises en faisceau et sectionnées afin de former un microréseau mince qui peut être collé sur un support. L'invention concerne aussi des utilisations et des procédés de fabrication des microréseaux construits en partie par sectionnement de faisceaux de tubules ou de tiges contenant des molécules bioréactives immobilisées dans une matrice afin de produire des nombres importants de puces échantillons. Les puces ainsi produites sont traitées par déposition sur les microréseaux. Les puces déposées peuvent être manipulées afin de réaliser une partition entre la matrice d'immobilisation et les molécules bioréactives contenues dans la matrice et de placer les molécules séparées sur des surfaces variées aux fins d'analyses subséquentes, comprenant des tests de liaison, des réactions d'hybridation, des méthodes de diagnostic et une variété de méthodologies de détermination d'interactions cellulaires.
PCT/US2001/023632 2000-07-28 2001-07-27 Microreseaux et leur fabrication par tranchage WO2002010761A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001280833A AU2001280833A1 (en) 2000-07-28 2001-07-27 Microarrays and their manufacture by slicing

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US09/628,339 2000-07-28
US09/628,339 US6846635B1 (en) 1999-07-30 2000-07-28 Microarrays and their manufacture
US09/772,974 US6653151B2 (en) 1999-07-30 2001-01-31 Dry deposition of materials for microarrays using matrix displacement
US09/772,974 2001-01-31
US09/774,794 US20020015952A1 (en) 1999-07-30 2001-02-01 Microarrays and their manufacture by slicing
US09/774,794 2001-02-01

Publications (1)

Publication Number Publication Date
WO2002010761A1 true WO2002010761A1 (fr) 2002-02-07

Family

ID=27417445

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/023632 WO2002010761A1 (fr) 2000-07-28 2001-07-27 Microreseaux et leur fabrication par tranchage

Country Status (2)

Country Link
AU (1) AU2001280833A1 (fr)
WO (1) WO2002010761A1 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002082080A2 (fr) * 2001-04-05 2002-10-17 GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) Procede pour produire plusieurs copies identiques d'un jeu ordonne plan de molecules sondes
FR2857099A1 (fr) * 2003-07-04 2005-01-07 Jean Marie Billiotte Procede et dispositif d'analyse chimique ou biologique par senseur a chambre monolithique en gerbe multi-micro-tubulaire et transducteur lateral de mesure integrale
JP2005529309A (ja) * 2001-11-01 2005-09-29 レンセレアー ポリテクニック インスティテュート 生体触媒ゾルゲルマイクロアレイ
EP1681921A2 (fr) * 2003-10-23 2006-07-26 Georgetown University Procede de microassemblage bi- et tridimensionnel de motifs et de structures
WO2014185960A2 (fr) 2013-05-14 2014-11-20 Genomics Usa, Inc. Composition et procédés pour piéger une protéine sur une surface
EP2593229B1 (fr) * 2010-07-13 2020-05-13 Dublin City University Methode d'analyse et de sélection directes de clones
CN115128148A (zh) * 2022-05-18 2022-09-30 上海交通大学 一种单细胞蛋白检测双层水凝胶及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210910B1 (en) * 1998-03-02 2001-04-03 Trustees Of Tufts College Optical fiber biosensor array comprising cell populations confined to microcavities

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210910B1 (en) * 1998-03-02 2001-04-03 Trustees Of Tufts College Optical fiber biosensor array comprising cell populations confined to microcavities

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002082080A3 (fr) * 2001-04-05 2003-09-12 Biotechnolog Forschung Gmbh Procede pour produire plusieurs copies identiques d'un jeu ordonne plan de molecules sondes
WO2002082080A2 (fr) * 2001-04-05 2002-10-17 GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) Procede pour produire plusieurs copies identiques d'un jeu ordonne plan de molecules sondes
US7267958B2 (en) 2001-11-01 2007-09-11 Rensselaer Polytechnic Institute Biocatalytic solgel microarrays
US7846747B2 (en) 2001-11-01 2010-12-07 Rensselaer Polytechnic Institute Biocatalytic solgel microarrays
JP2005529309A (ja) * 2001-11-01 2005-09-29 レンセレアー ポリテクニック インスティテュート 生体触媒ゾルゲルマイクロアレイ
WO2005011866A1 (fr) * 2003-07-04 2005-02-10 Magnisense Limited Procede et dispositif d’analyse chimique ou biologique par senseur a chambre monolithique en gerbe multi-micro-tubulaire et transducteur lateral de mesure integrale
FR2857099A1 (fr) * 2003-07-04 2005-01-07 Jean Marie Billiotte Procede et dispositif d'analyse chimique ou biologique par senseur a chambre monolithique en gerbe multi-micro-tubulaire et transducteur lateral de mesure integrale
EP1681921A2 (fr) * 2003-10-23 2006-07-26 Georgetown University Procede de microassemblage bi- et tridimensionnel de motifs et de structures
EP1681921A4 (fr) * 2003-10-23 2011-08-10 Univ Georgetown Procede de microassemblage bi- et tridimensionnel de motifs et de structures
US8349584B2 (en) 2003-10-23 2013-01-08 Georgetown University Microarrays and their manufacture
EP2593229B1 (fr) * 2010-07-13 2020-05-13 Dublin City University Methode d'analyse et de sélection directes de clones
WO2014185960A2 (fr) 2013-05-14 2014-11-20 Genomics Usa, Inc. Composition et procédés pour piéger une protéine sur une surface
EP2997037A4 (fr) * 2013-05-14 2017-03-08 Genomics Usa, Inc. Composition et procédés pour piéger une protéine sur une surface
US11260363B2 (en) 2013-05-14 2022-03-01 Pure Transplant Solutions L.L.C. Compositions and methods for entrapping protein on a surface
CN115128148A (zh) * 2022-05-18 2022-09-30 上海交通大学 一种单细胞蛋白检测双层水凝胶及其制备方法和应用

Also Published As

Publication number Publication date
AU2001280833A1 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
US7179638B2 (en) Microarrays and their manufacture by slicing
US6846635B1 (en) Microarrays and their manufacture
US6653151B2 (en) Dry deposition of materials for microarrays using matrix displacement
US20020015952A1 (en) Microarrays and their manufacture by slicing
US10927406B2 (en) Microarray system and a process for detecting target analytes using the system
JP4361271B2 (ja) アッセイ、合成、および保存用の器具、ならびに、その作製、使用、および操作の方法
JP4307380B2 (ja) チップ基材上でのゲル化反応により作製されたバイオチップ
US20090156426A1 (en) Functionalized porous supports for microarrays
US20030203366A1 (en) Microarray channel devices produced by a block mold process
WO2002010761A1 (fr) Microreseaux et leur fabrication par tranchage
Anderson Microarrays and their manufacture by slicing
WO2003064997A2 (fr) Microreseaux produits par la formation de parties transversales dans des plaques comportant plusieurs echantillons
US20020129889A1 (en) Method and apparatus for making fibers for sectioned arrays

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP